(ROOT
  (X
    (X
      (NP
        (NP (NNP Down-regulation))
        (PP (IN of)
          (NP (NN interferon))))
      (NP (JJ regulatory) (NN factor))
      (NP
        (NP (CD 4) (NN gene) (NN expression))
        (PP (IN in)
          (NP (JJ leukemic) (NNS cells)))))
    (ADJP (JJ due)
      (PP (TO to)
        (NP
          (NP (NN hypermethylation))
          (PP (IN of)
            (NP (NNP CpG) (NNS motifs)))))
      (PP (IN in)
        (NP
          (NP (DT the) (NN promoter) (NN region) (NN Abstract))
          (SBAR
            (S
              (SBAR (IN Although)
                (S
                  (NP (DT the) (JJ bcr-abl) (NN translocation))
                  (VP (VBZ has)
                    (VP (VBN been)
                      (VP (VBN shown)
                        (S
                          (VP (TO to)
                            (VP (VB be)
                              (NP
                                (NP (DT the) (JJ causative) (JJ genetic) (NN aberration))
                                (PP (IN in)
                                  (NP
                                    (NP (JJ chronic) (JJ myeloid) (NN leukemia))
                                    (PRN (-LRB- -LRB-)
                                      (NP (NNP CML))
                                      (-RRB- -RRB-)))))))))))))
              (, ,)
              (NP (EX there))
              (VP (VBZ is)
                (NP (VBG mounting) (NN evidence)
                  (SBAR (IN that)
                    (S
                      (NP
                        (NP (DT the) (NN deregulation))
                        (PP (IN of)
                          (NP (JJ other) (NNS genes)))
                        (, ,)
                        (PP (JJ such) (IN as)
                          (NP
                            (NP (DT the) (NN transcription) (NN factor))
                            (VP (VBN interferon)
                              (NP
                                (NP (JJ regulatory) (NN factor) (CD 4))
                                (PRN (-LRB- -LRB-)
                                  (NP (NNP IRF-4))
                                  (-RRB- -RRB-))))))
                        (, ,))
                      (VP (VBZ is)
                        (ADVP (RB also))
                        (VP (VBN implicated)
                          (PP (IN in)
                            (NP
                              (NP (DT the) (NNS pathogenesis))
                              (PP (IN of)
                                (NP (NNP CML)))))))))))))))
      (. .))))

(ROOT
  (S
    (NP
      (NP
        (NP (JJ Promoter) (NN methylation))
        (PP (IN of)
          (NP (NNP CpG) (NN target) (NNS sites))))
      (CC or)
      (NP
        (NP (JJ direct) (NNS deletions/insertions))
        (PP (IN of)
          (NP (NNS genes)))))
    (VP (VBP are)
      (NP
        (NP (NNS mechanisms))
        (PP (IN of)
          (NP
            (NP (DT a)
              (ADJP (JJ reversible)
                (CC or)
                (JJ permanent))
              (NN silencing))
            (PP (IN of)
              (NP (NN gene) (NN expression))))))
      (, ,)
      (ADVP (RB respectively)))
    (. .)))

(ROOT
  (S
    (ADVP (RB Therefore))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (SBAR (IN whether)
        (S
          (NP
            (NP (NN IRF-4) (NN promoter) (NN methylation))
            (CC or)
            (NP (NN mutation)))
          (VP (MD may)
            (VP (VB be)
              (VP (VBN involved)
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN regulation))
                    (PP (IN of)
                      (NP (NN IRF-4) (NN expression)))))
                (PP (IN in)
                  (NP (NN leukemia) (NNS cells)))))))))
    (. .)))

(ROOT
  (S
    (SBAR (IN Whereas)
      (S
        (NP
          (NP (NN promoter) (NNS mutations))
          (CC or)
          (NP (JJ structural) (NNS rearrangements)))
        (VP (MD could)
          (VP (VB be)
            (VP (VBN excluded)
              (PP (IN as)
                (NP
                  (NP (DT a) (NN cause))
                  (PP (IN of)
                    (NP
                      (NP (JJ altered) (NN IRF-4) (NN expression))
                      (PP (IN in)
                        (NP (JJ hematopoietic) (NNS cells))))))))))))
    (, ,)
    (NP (DT the) (NNP IRF-4) (NN promoter) (NN methylation) (NN status))
    (VP (VBD was)
      (VP (VBN found)
        (S
          (VP (TO to)
            (VP
              (ADVP (RB significantly))
              (VB influence)
              (NP (NN IRF-4) (NN transcription)))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB First))
    (, ,)
    (NP
      (NP (NN treatment))
      (PP (IN of)
        (NP (NN IRF-4-negative)
          (ADJP (JJ lymphoid) (, ,) (JJ myeloid)
            (CC and)
            (JJ monocytic))
          (NN cell) (NNS lines)))
      (PP (IN with)
        (NP (DT the) (JJ methylation-inhibitor) (NN 5-aza-2-deoxycytidine))))
    (VP (VBD resulted)
      (PRT (RP in))
      (NP
        (NP (DT a) (NN time))
        (: -)
        (CC and)
        (NP
          (NP (JJ concentration-dependent) (NN increase))
          (PP (IN of)
            (NP (NN IRF-4) (NN mRNA)
              (CC and)
              (NN protein) (NNS levels))))))
    (. .)))

(ROOT
  (S
    (ADVP (LS Second))
    (, ,)
    (VP
      (VP (VBG using)
        (NP (DT a) (NN restriction-PCR-assay)))
      (CC and)
      (VP (VBG bisulfite-sequencing)
        (S
          (NP (PRP we))
          (VP (VBN identified)
            (ADVP (RB specifically))))))
    (VP (VBD methylated)
      (NP (NNP CpG) (NNS sites))
      (PP
        (PP (IN in)
          (NP (NNS IRF-4-negative)))
        (CONJP (CC but)
          (RB not))
        (PP (IN in)
          (NP (NN IRF-4-positive) (NNS cells)))))
    (. .)))

(ROOT
  (S
    (ADVP (LS Third))
    (, ,)
    (NP (PRP we))
    (ADVP (RB clearly))
    (VP
      (VP (VBD determined)
        (NP (NN promoter) (NN methylation))
        (PP (IN as)
          (NP
            (NP (DT a) (NN mechanism))
            (PP (IN for)
              (NP
                (NP (NN IRF-4) (NN down-regulation))
                (PP (IN via)
                  (NP (NN reporter) (NN gene) (NNS assays))))))))
      (, ,)
      (CC but)
      (VP (VBD did) (RB not)
        (VP (VB detect)
          (NP
            (NP (DT an) (NN association))
            (PP (IN of)
              (NP
                (NP (JJ methylational) (NN status)
                  (CC and)
                  (NN mRNA) (NN expression))
                (PP (IN of)
                  (NP
                    (NP (NN DNA) (NNS methyltransferases))
                    (CC or)
                    (NP (JJ methyl-CpG-binding) (NNS proteins))))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Together))
    (, ,)
    (NP (DT these) (NNS data))
    (VP (VBP suggest)
      (NP
        (NP (NNP CpG) (NNP site-specific) (NNP IRF-4) (NN promoter) (NN methylation))
        (PP (IN as)
          (NP
            (NP (DT a) (JJ putative) (NN mechanism))
            (PP (IN of)
              (NP
                (NP (JJ down-regulated) (NN IRF-4) (NN expression))
                (PP (IN in)
                  (NP (NN leukemia)))))))))
    (. .)))

(ROOT
  (S
    (NP (NNP INTRODUCTION) (NNP Chronic))
    (VP (VBD myeloid)
      (SBAR
        (S
          (NP
            (NP (NN leukemia))
            (PRN (-LRB- -LRB-)
              (NP (NNP CML))
              (-RRB- -RRB-)))
          (VP (VBZ is)
            (NP
              (NP (DT a) (JJ clonal) (NN myeloproliferative) (NN disorder))
              (PP (IN with)
                (NP
                  (NP (DT a) (JJ typical) (CD three))
                  (VP (VBN phased)
                    (NP
                      (NP
                        (NP (NN course))
                        (PRN (-LRB- -LRB-)
                          (NP
                            (NP (NN chronic))
                            (, ,)
                            (NP (JJ accelerated)
                              (CC and)
                              (JJ blastic) (NN phase)))
                          (-RRB- -RRB-)))
                      (VP (VBG reflecting)
                        (NP
                          (NP (DT the) (NN loss))
                          (PP (IN of)
                            (NP
                              (ADJP (JJ differentiation)
                                (CC and)
                                (JJ malignant))
                              (NN progress)))
                          (SBAR
                            (WHNP (WDT which))
                            (S
                              (ADVP (RB inevitably))
                              (VP (VBZ leads)
                                (PP (TO to)
                                  (NP (NN death)))
                                (PP (IN after)
                                  (NP (DT the) (JJ blastic) (NN phase))))))))
                      (PRN (-LRB- -LRB-)
                        (NP (CD 1,2))
                        (-RRB- -RRB-)))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NN hallmark) (JJ genetic) (NN aberration))
      (PP (IN of)
        (NP (NNP CML))))
    (VP (VBZ is)
      (NP
        (NP
          (NP (DT a) (JJ reciprocal) (JJ chromosomal) (NN translocation) (NN t))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (CD 9))
              (: ;)
              (NP (CD 22)))
            (-RRB- -RRB-)))
        (VP (VBG leading)
          (PP (TO to)
            (NP
              (NP (NN expression))
              (PP (IN of)
                (NP
                  (NP (DT a) (JJ bcr-abl) (NN fusion) (NN gene))
                  (, ,)
                  (NP (DT an) (JJ aberrant) (VBN activated) (NN tyrosine) (NN kinase)))))))
        (PRN (-LRB- -LRB-)
          (NP (CD 2))
          (-RRB- -RRB-))))
    (. .)))

(ROOT
  (S
    (NP
      (NP
        (NP (NNP Treatment))
        (PP (IN with)
          (NP (NN interferon) (NN α))))
      (PRN (-LRB- -LRB-)
        (NP (NNP IFN-α))
        (-RRB- -RRB-)))
    (VP
      (VP (VBZ prolongs)
        (NP
          (NP (NN survival))
          (PP (IN of)
            (NP (NNP CML) (NNS patients)))))
      (CC and)
      (VP (VBZ is)
        (VP (VBN associated)
          (PP (IN with)
            (NP
              (NP
                (NP
                  (NP (DT a) (JJ complete) (JJ cytogenetic) (NN response))
                  (PP (IN in)
                    (NP (CD 5))))
                (: --)
                (NP
                  (NP (CD 33) (NN %))
                  (PP (IN of)
                    (NP (NNP CML) (NNS patients)))))
              (PRN (-LRB- -LRB-)
                (NP (CD 1,2))
                (-RRB- -RRB-)))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Recently))
    (, ,)
    (NP (PRP we))
    (VP (VBD described)
      (NP
        (NP (DT an) (VBN impaired) (NN expression))
        (PP (IN of)
          (NP
            (NP (DT the) (JJ interferon) (JJ regulatory) (NN factor) (CD 4) (-LRB- -LRB-) (NN IRF-4) (-RRB- -RRB-))
            (PP (IN in)
              (NP (NNP CML))))))
      (, ,)
      (S
        (VP (VBG correlating)
          (PP (IN with)
            (NP (JJ poor) (NN response)))
          (PP (TO to)
            (NP
              (NP (JJ IFN-α) (NN treatment))
              (PRN (-LRB- -LRB-)
                (NP (CD 3))
                (-RRB- -RRB-)))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NN cause))
      (PP (IN of)
        (NP
          (NP (DT the) (NN silencing))
          (PP (IN of)
            (NP (NN IRF-4) (NN level))))))
    (VP (VBD remained)
      (ADJP (JJ unclear)))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Interferon) (JJ regulatory) (NNS factors))
      (PRN (-LRB- -LRB-)
        (NP (NNP IRFs))
        (-RRB- -RRB-)))
    (VP (VBP are)
      (NP
        (NP (DT a) (NN family))
        (PP (IN of)
          (NP
            (NP (JJ transcriptional) (NNS regulators))
            (VP (VBN defined)
              (PP (IN by)
                (NP
                  (NP (DT a) (JJ characteristic) (NN homology))
                  (PP (IN in)
                    (NP (PRP$ their) (JJ DNA-binding) (NN domain))))))))))
    (. .)))

(ROOT
  (S
    (NP (PRP They))
    (VP (VBP play)
      (NP
        (NP (DT an) (JJ important) (NN role))
        (PP (IN in)
          (NP
            (NP (DT the) (NN regulation))
            (PP (IN of)
              (NP
                (NP
                  (NP (JJ various) (NNS genes))
                  (PRN (-LRB- -LRB-)
                    (PP (JJ such) (IN as)
                      (NP
                        (NP (NNP IFNs))
                        (, ,)
                        (NP
                          (NP (NNS interleukins))
                          (, ,)
                          (NP (NNP MHC) (NN class) (NNP I/II)))))
                    (-RRB- -RRB-)))
                (, ,)
                (NP (NNS apoptosis))
                (CC and)
                (NP
                  (NP (NN differentiation/maturation))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (CD 4))
                      (: --)
                      (NP (CD 6)))
                    (-RRB- -RRB-)))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP
        (NP (NN IRF-4))
        (PRN (-LRB- -LRB-)
          (NP (NNP ICSAT/Pip/MUM1) (NNP /) (NNP LSIRF))
          (-RRB- -RRB-)))
      (VP (VBZ is)
        (NP
          (NP (CD one) (NN member))
          (PP (IN with)
            (NP
              (ADJP (RB very) (JJ restricted))
              (NN expression) (NN pattern))))))
    (: :)
    (S
      (NP
        (NP (NNP Predominately) (NNP B))
        (: -)
        (CC and)
        (NP (VBN activated) (NNS T-lymphocytes)))
      (VP (VBP are)
        (ADJP
          (ADJP (JJ IRF-4) (JJ positive))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (CD 7))
              (: --)
              (NP (CD 11)))
            (-RRB- -RRB-)))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP (NN contrast))
        (PP (TO to)
          (NP (JJ other) (NNS IRFs)))))
    (, ,)
    (NP
      (NP (NN expression))
      (PP (IN of)
        (NP (NN IRF-4))))
    (VP (MD can) (RB not)
      (VP (VB be)
        (VP (VBN induced)
          (PP
            (PP (IN by)
              (NP (NNP IFNs)))
            (, ,)
            (CC but)
            (PP (IN by)
              (NP
                (NP (NN antigen) (NN stimulation))
                (, ,)
                (NP
                  (NP
                    (NP (VBG crosslinking))
                    (PP (IN of)
                      (NP (NNP T))))
                  (: -)
                  (CC or)
                  (NP
                    (NP (JJ B-cell) (NNS receptors))
                    (CC or)
                    (NP
                      (NP (NN phorbol-myristate-acetate))
                      (PRN (-LRB- -LRB-)
                        (NP (CD 10,11))
                        (-RRB- -RRB-)))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Consistent))
      (PP (IN with)
        (NP
          (NP
            (NP (DT the) (NN restriction))
            (PP (IN of)
              (NP (NN expression)))
            (S
              (VP (TO to)
                (VP (VB immunocompetent)
                  (NP (NNS cells))))))
          (, ,)
          (NP
            (NP (NNS mice))
            (PP (IN with)
              (NP
                (NP (NN deletion))
                (PP (IN of)
                  (NP
                    (NP (NN IRF-4))
                    (VP (VBN failed)
                      (S
                        (VP (TO to)
                          (VP (VB develop)
                            (NP
                              (ADJP
                                (ADJP (JJ mature))
                                (CC and)
                                (ADJP (RB functionally) (JJ active)))
                              (NN B)))))))))))
          (: -)
          (CC and)
          (NP
            (NP (NNP T-lymphocytes))
            (PRN (-LRB- -LRB-)
              (NP (CD 12))
              (-RRB- -RRB-))
            (, ,)
            (CC and)
            (NP
              (NP (DT the) (VBN impaired) (NN expression))
              (PP (IN of)
                (NP (NN IRF-4)))
              (PP (IN in)
                (NP (NNP CML))))))))
    (VP (VBD was)
      (ADVP (RB predominately))
      (VP (VBN found)
        (PP (IN in)
          (NP
            (NP (NNP T-cells))
            (PRN (-LRB- -LRB-)
              (NP (CD 3))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (NP (DT These) (NNS data))
    (VP (VBP suggest)
      (NP
        (NP (DT a) (JJ crucial) (NN role))
        (PP (IN for)
          (NP (NN IRF-4))))
      (PP (IN in)
        (NP
          (NP (DT the) (NN function))
          (PP (IN of)
            (NP (JJ immune) (NNS cells))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP
        (NP (NNP Methylation))
        (PP (IN of)
          (NP
            (NP (JJ dinucleotide) (JJ cytosine-guanosine) (NNS motifs))
            (PRN (-LRB- -LRB-)
              (NP (NNP CpG))
              (-RRB- -RRB-)))))
      (, ,) (RB especially) (IN in)
      (NP
        (NP (NNP CpG) (NNS islands))
        (VP (VBN located)
          (PP (IN in)
            (NP (NN promoter) (NNS regions)))))
      (, ,))
    (VP (VBZ is)
      (NP
        (NP (CD one))
        (PP (IN of)
          (NP
            (NP
              (NP (DT the) (NNS mechanisms))
              (PP (IN of)
                (NP
                  (NP (NN gene) (NN regulation))
                  (PP (IN in)
                    (NP (NNS mammals))))))
            (CC and)
            (NP
              (NP (DT a) (JJ common) (NN event))
              (PP (IN of)
                (NP
                  (NP (NN gene))
                  (VP (VBG silencing)
                    (PP (IN in)
                      (NP
                        (NP (JJ human) (NNS neoplasias))
                        (PRN (-LRB- -LRB-)
                          (NP (CD 13,14))
                          (-RRB- -RRB-))))))))))))
    (. .)))

(ROOT
  (S
    (SBAR (IN As)
      (S
        (VP (VBN opposed)
          (PP (TO to)
            (NP (JJ normal) (NNS cells))))))
    (, ,)
    (NP
      (NP (NN hypermethylation))
      (PP (IN of)
        (NP (NNP CpG) (NNS islands))))
    (VP (VBZ is)
      (NP
        (NP (DT a)
          (ADJP
            (ADVP (RB frequently))
            (JJ observed))
          (NN phenomenon))
        (PP (IN in)
          (NP (DT every) (NN cancer) (NN type)))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP De) (NN novo) (NN DNA) (NN methylation))
      (PP (IN of)
        (NP
          (NP (NNS genes))
          (PP (JJ such) (IN as)
            (NP
              (NP (NN cell) (NN cycle))
              (, ,)
              (NP (NN DNA) (NN repair))
              (, ,)
              (NP (NNS apoptosis))
              (CC and)
              (NP (NN tumor) (NN suppressor) (NNS genes)))))))
    (VP (VBZ is)
      (ADVP (RB therefore))
      (VP (VBN thought)
        (S
          (VP (TO to)
            (VP (VB be)
              (VP (VBN involved)
                (PP (IN in)
                  (NP
                    (NP (NNS tumorigenesis))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 15))
                        (: --)
                        (NP (CD 17)))
                      (-RRB- -RRB-))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNS Examples))
      (PP (IN for)
        (NP (JJ such) (JJ aberrated) (NNS genes))))
    (VP (VBP are)
      (NP
        (NP (NNP MGMT) (, ,) (NNPS DAPK) (, ,) (NNPS p14ARF) (, ,) (NNPS p15INK4b) (, ,) (NNPS p16INK4a) (, ,) (NNPS BRCA1) (, ,) (NNPS CDH13)
          (CC and)
          (NNPS APAF-1))
        (PRN (-LRB- -LRB-)
          (NP
            (NP (CD 17))
            (: --)
            (NP (CD 19)))
          (-RRB- -RRB-))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (NNP CML)))
    (, ,)
    (S
      (NP (NN methylation))
      (VP (VBZ is)
        (VP (VBN known)
          (S
            (VP (TO to)
              (VP (VB regulate)
                (NP
                  (NP (NN expression))
                  (PP (IN of)
                    (NP
                      (NP (DT the) (NN c-abl))
                      (, ,)
                      (NP (DT the) (NN bcr) (NN gene))
                      (CC and)
                      (NP (NNS others))
                      (PRN (-LRB- -LRB-)
                        (NP
                          (NP (CD 20))
                          (: --)
                          (NP (CD 23)))
                        (-RRB- -RRB-)))))))))))
    (, ,)
    (CC and)
    (S
      (NP
        (NP (DT the) (NN extent))
        (PP (IN of)
          (NP
            (NP (NN methylation))
            (PP (IN in)
              (NP (DT the) (JJ c-abl) (NN promoter))))))
      (VP (VBZ has)
        (VP (VBN been)
          (VP (VBN shown)
            (S
              (VP (TO to)
                (VP (VB be)
                  (VP (VBN associated)
                    (PP (IN with)
                      (NP
                        (NP (JJ advanced) (NN disease))
                        (PRN (-LRB- -LRB-)
                          (NP (CD 24))
                          (-RRB- -RRB-))))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ Hypermethylation)
        (ADJP (JJ due)
          (PP (TO to)
            (NP
              (NP (NN overexpression))
              (PP (IN of)
                (NP (NNP DNA))))))
        (NNS methyltransferases))
      (PRN (-LRB- -LRB-)
        (NP (NNP DNMTs))
        (-RRB- -RRB-)))
    (VP (VBZ remains)
      (NP
        (NP (CD one) (JJ possible) (NN explanation))
        (PP (IN for)
          (NP
            (NP (IN de) (JJ novo) (NN methylation))
            (PP (IN in)
              (NP (NNS tumorigenesis)))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Recently))
    (, ,)
    (NP (NNP DNMTs))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB be)
                (VP (VBN up-regulated)
                  (PP (IN in)
                    (NP
                      (NP (JJ hematopoietic) (NNS malignancies))
                      (PRN (-LRB- -LRB-)
                        (NP (CD 25))
                        (-RRB- -RRB-)))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ Methyl-CpG-binding) (NNS proteins))
      (PRN (-LRB- -LRB-)
        (NP (NNP MBPs))
        (-RRB- -RRB-)))
    (VP
      (VP (VBP are)
        (VP (VBN thought)
          (S
            (VP (TO to)
              (VP (VB inhibit)
                (NP
                  (NP (DT the) (NN binding))
                  (PP (IN of)
                    (NP (JJ transcriptional) (NNS factors))))
                (PP (TO to)
                  (NP (DT the) (NN promoter))))))))
      (CC and)
      (VP (VBP are)
        (ADVP (RB therefore))
        (VP (VBN discussed)
          (PP (IN as)
            (NP
              (NP (CD one) (NN mechanism))
              (PP (IN of)
                (NP (NN transcription) (NN inhibition)))))
          (PP (IN by)
            (NP
              (NP (NN hypermethylation))
              (PRN (-LRB- -LRB-)
                (NP (CD 26))
                (-RRB- -RRB-)))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN work)))
    (, ,)
    (NP (PRP we))
    (VP (VBD studied)
      (NP
        (NP (NNS mechanisms))
        (PP (IN of)
          (NP
            (NP (NN IRF-4) (NN gene) (NN expression))
            (VP (VBG silencing)
              (PP (IN in)
                (NP (JJ leukemic) (NNS cells))))))))
    (. .)))

(ROOT
  (S
    (NP (PRP We))
    (VP (VBD analyzed)
      (NP (DT the) (NN IRF-4) (NN promoter) (NN region))
      (PP (IN for)
        (NP
          (NP (JJ genetic) (NNS aberrations))
          (CC and)
          (NP (JJ methylational) (NN status))))
      (PP (IN in)
        (NP
          (ADJP (JJ IRF-4-positive)
            (CC and)
            (JJ -))
          (JJ negative) (JJ hematopoietic) (NNS cells))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP MATERIALS)
        (CC AND)
        (NNP METHODS) (NNP K-562))
      (, ,)
      (NP (NNP Jurkat))
      (CC and)
      (NP (NN U-937)))
    (VP (VBD were)
      (VP
        (VP (VBN obtained)
          (PP (IN from)
            (NP
              (NP (DT the) (NN ATCC))
              (PRN (-LRB- -LRB-)
                (NP (NNP American) (NNP Type) (NNP Culture) (NNP Collection))
                (, ,)
                (NP (NNP Rockville))
                (, ,)
                (NP (NNP USA))
                (-RRB- -RRB-)))))
        (CC and)
        (VP
          (ADJP (JJ EM-2) (, ,) (JJ LAMA-84) (, ,) (JJ CML-T1) (, ,) (JJ BV-173) (, ,) (JJ SD-1)
            (CC and)
            (JJ RPMI-8226))
          (PP (IN from)
            (NP
              (NP (DT the) (NN DSMZ))
              (PRN (-LRB- -LRB-)
                (NP (NNP Deutsche) (NNP Sammlung) (NNP von) (NNP Mikroorganismen) (NNP und) (NNP Zellkulturen) (NNP GmbH))
                (, ,)
                (NP (NNP Braunschweig))
                (, ,)
                (NP (NNP Germany))
                (-RRB- -RRB-)))))))
    (. .)))

(ROOT
  (S
    (NP (DT All) (NN cell) (NNS lines))
    (, ,)
    (PP (IN except)
      (NP (NNP BV-173) (, ,) (NNP SD-1)
        (CC and)
        (NNP RPMI-8226)))
    (, ,)
    (VP (VBD were)
      (ADJP (JJ IRF-4-negative)))
    (. .)))

(ROOT
  (SINV
    (S
      (NP (DT All) (NN cell) (NNS lines))
      (VP (VBD were)
        (VP (VBN maintained)
          (PP (IN at)
            (NP
              (NP
                (ADJP (CD 5) (NN %))
                (NN CO2))
              (PP (IN in)
                (NP (NNP RPMI) (CD 1640) (NN medium)))))
          (PP (IN with)
            (NP
              (NP
                (ADJP (CD 1) (NN %))
                (NN glutamine))
              (PRN (-LRB- -LRB-)
                (NP (NNP Gibco/BRL) (NNP Eggenstein))
                (, ,)
                (NP (NNP Germany))
                (-RRB- -RRB-)))))))
    (VP (VBD supplemented)
      (PP (IN with)
        (NP (CD 10) (NN %))))
    (NP
      (NP (JJ fetal) (NN calf) (NN serum))
      (PRN (-LRB- -LRB-)
        (NP (NNP Gibco/BRL))
        (-RRB- -RRB-))
      (, ,)
      (NP
        (NP
          (ADJP (CD 1) (NN %))
          (NN penicillin/streptomycin))
        (PRN (-LRB- -LRB-)
          (NP (NNP Biochrom))
          (, ,)
          (NP (NNP Berlin))
          (, ,)
          (NP (NNP Germany))
          (-RRB- -RRB-))))
    (. .)))

(ROOT
  (S
    (SBAR
      (WHADVP (WRB When))
      (S
        (VP (VBD indicated))))
    (, ,)
    (NP (NNS cells))
    (VP (VBD were)
      (VP (VBN treated)
        (PP (IN with)
          (NP
            (NP
              (NP (JJ 5-aza-2-deoxycytidine))
              (PRN (-LRB- -LRB-)
                (NP (NNP AzadC))
                (-RRB- -RRB-)))
            (CC or)
            (NP
              (NP
                (NP (JJ 5-azacytidine))
                (PRN (-LRB- -LRB-)
                  (NP (NNP AzaC))
                  (-RRB- -RRB-)))
              (PRN (-LRB- -LRB-)
                (NP (NNP Sigma))
                (, ,)
                (NP (NNP Taufkirchen))
                (, ,)
                (NP (NNP Germany))
                (-RRB- -RRB-)))))
        (PP (IN for)
          (NP (JJ different) (NN time) (NNS periods)))))
    (. .)))

(ROOT
  (SINV
    (VP (VBG Owing)
      (PP (TO to)
        (NP (PRP$ their) (JJ chemical) (NN instability) (JJ fresh) (NNS substances))))
    (VP (VBD were)
      (VP (VBN re-added)
        (S
          (S
            (NP (DT every) (CD 24) (NN h.))
            (PP (IN For)
              (NP
                (NP (NN analysis))
                (PP (IN of)
                  (NP
                    (NP (DT the) (NN IRF-4) (NN promoter) (NN region))
                    (PP (IN for)
                      (NP
                        (NP (JJ permanent) (NNS aberrations))
                        (PP (JJ such) (IN as)
                          (NP (NNS insertions/deletions)
                            (CC or)
                            (NN mutation))))))))))
          (, ,)
          (S
            (NP (PRP we))
            (ADJP (JJ PCR-amplified))))))
    (NP
      (NP (CD two) (NNS fragments))
      (PP (IN from)
        (NP (JJ genomic) (NN DNA)))
      (, ,)
      (SBAR
        (WHNP (WDT which))
        (S
          (VP (VBD was)
            (VP (VBN extracted)
              (PP (IN from)
                (NP (JJ depicted) (NN cell) (NNS lines)))
              (PP (IN with)
                (NP
                  (NP (DT a) (JJ commercial) (NN kit))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP Qiagen))
                    (, ,)
                    (NP (NNP Hilde))
                    (, ,)
                    (NP (NNP Germany))
                    (-RRB- -RRB-))
                  (SBAR (IN as)
                    (S
                      (VP (VBD recommended)))))))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NNS primers))
    (VP (VBD were)
      (NP
        (NP (JJ 1-forward))
        (: :)
        (NP (CD 5) (NNS ′))
        (: -)
        (NP (NNP TTGAGATGGAGTCTTGCTCTGT-3) (CD ′) (, ,) (CD 1-reverse))
        (: :)
        (NP (CD 5) (NNS ′))
        (: -)
        (NP (NNP CCAGGACCTCAGGAGGCCAGTCA-3) (NNP ′))
        (: ;)
        (NP (JJ 2-forward))
        (: :)
        (NP (CD 5) (NNS ′))
        (: -)
        (NP (NNP AGCGGTGAAACTGAGAGTGCGAGGT-3) (CD ′) (, ,) (CD 2-reverse))
        (: :)
        (NP
          (NP (CD 5) (NNS ′))
          (: -)
          (NP (NNP GCCACATCGCTGCAGTTTAG-3) (NNP ′)))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NNS products))
    (VP (VBD were)
      (VP (VBN cloned)
        (PP (IN with)
          (NP
            (NP (DT the) (`` `) (NNP TOPO) (NNP TA) (NN cloning) (NN kit) ('' '))
            (PRN (-LRB- -LRB-)
              (NP (NNP Invitrogen))
              (, ,)
              (NP (NNP Groningen))
              (, ,)
              (NP (DT The) (NNPS Netherlands))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (SBAR (IN After)
      (S
        (NP
          (NP (JJ bacterial) (NN amplification))
          (PP (IN of)
            (NP (DT the) (NNP cloned) (NNP PCR))))
        (VP (VBZ fragments)
          (PP (IN by)
            (NP (JJ standard) (NNS procedures))))))
    (, ,)
    (NP
      (NP
        (QP (IN at) (JJS least) (CD three))
        (NNS clones))
      (PP (IN from)
        (NP (DT each) (NN sample))))
    (VP (VBD were)
      (VP (VBN sequenced)
        (PP (IN with)
          (NP
            (NP (DT an) (JJ automated) (NN sequencer))
            (PRN (-LRB- -LRB-)
              (NP
                (NP (NNP ABI) (NNP Prism) (NNP 377))
                (, ,)
                (NP (NNP Applied) (NNP Bio-systems))
                (, ,)
                (NP (NNP Foster) (NNP City))
                (, ,)
                (NP (NNP USA)))
              (-RRB- -RRB-))
            (SBAR (IN as)
              (S
                (VP (VBD recommended)
                  (PP (IN by)
                    (NP (DT the) (NN manufacturer))))))))))
    (. .)))

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB analyze)
          (NP (DT the)
            (ADJP (JJ IRF-4) (JJ transcriptional))
            (NN level)))))
    (, ,)
    (NP (NNP RNA))
    (VP (VBD was)
      (VP (VBN extracted)
        (PP (IN from)
          (NP
            (NP (NNS cells))
            (VP (VBG using)
              (NP
                (NP (DT the) (JJ commercial) (NN RNAzol-kit))
                (PRN (-LRB- -LRB-)
                  (NP (NNP Paesel))
                  (, ,)
                  (NP (NNP Frankfurt))
                  (, ,)
                  (NP (NNP Germany))
                  (-RRB- -RRB-))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT An) (NN aliquot))
      (PP (IN of)
        (NP (CD 1) (NN μg))))
    (VP (VBP total)
      (SBAR
        (S
          (NP (NNP RNA))
          (VP (VBD was)
            (VP (VBN used)
              (PP (IN for)
                (NP
                  (NP (NN cDNA) (NN synthesis))
                  (SBAR (IN as)
                    (S
                      (VP (VBD described)
                        (ADVP (RB previously)))))
                  (PRN (-LRB- -LRB-)
                    (NP (CD 27))
                    (-RRB- -RRB-)))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP RNA) (NN expression) (NN analysis))
      (PP (IN for)
        (NP
          (NP (NN IRF-4))
          (CC and)
          (NP (DT the) (NN reference) (NN gene) (NN β-actin)))))
    (VP (VBD was)
      (VP (VBN carried)
        (PRT (RP out))
        (PP (IN by)
          (NP
            (NP (JJ semi-quantitative) (NN PCR) (IN as))
            (VP (VBN described)
              (ADVP (RB previously))
              (PRN (-LRB- -LRB-)
                (NP (CD 3,27))
                (-RRB- -RRB-)))))))
    (. .)))

(ROOT
  (S
    (NP (NNP PCR) (NNS products))
    (VP (VBD were)
      (VP (VBN verified)
        (PP (IN by)
          (NP (VBN automated) (NN sequencing)))))
    (. .)))

(ROOT
  (S
    (NP
      (NP
        (NP (NN PCR) (NNS primers)
          (CC and)
          (NNS conditions))
        (PP (IN for)
          (NP
            (NP (NN expression) (NN analysis))
            (PP (IN of)
              (NP (NNP DNMT)
                (CC or)
                (NNP MBP))))))
      (PRN (-LRB- -LRB-)
        (NP
          (NP (NNP DNMT1) (NNP DNMT3A))
          (, ,)
          (NP (NNP DNMT3B) (, ,) (NNP MeCP) (, ,) (NNP MBD1) (, ,) (NNP MBD2)
            (CC and)
            (NNP MBD4)))
        (-RRB- -RRB-)))
    (VP (VBD were)
      (VP (VBN published)
        (ADVP (RB elsewhere))
        (PRN (-LRB- -LRB-)
          (NP (CD 28))
          (-RRB- -RRB-))))
    (. .)))

(ROOT
  (S
    (PP (IN For)
      (NP
        (NP (NN analysis))
        (PP (IN of)
          (NP (NN IRF-4) (NN protein) (NN expression)))))
    (, ,)
    (NP (DT a) (JJ standard) (NN immunoblotting) (NN assay))
    (VP (VBD was)
      (VP (VBN performed)
        (SBAR (IN as)
          (FRAG
            (VP (VBN described)
              (ADVP (RB previously))
              (PRN (-LRB- -LRB-)
                (NP (CD 29))
                (-RRB- -RRB-)))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Briefly))
    (, ,)
    (NP (NN protein) (NNS lysates))
    (VP (VBD were)
      (VP (VBN generated)
        (PP (IN by)
          (S
            (VP (VBG incubating)
              (NP (CD 1) (NNP ×) (CD 106) (NNS cells))
              (PP (IN in)
                (NP
                  (NP
                    (NP (CD 100) (JJ µl) (NNP RIPA) (NN buffer))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP
                          (NP (CD 1) (NN %))
                          (NP (NN NP-40)))
                        (, ,)
                        (NP
                          (NP
                            (ADJP (CD 0.5) (NN %))
                            (NN sodiumdesoxycholate))
                          (, ,)
                          (NP
                            (ADJP (CD 0.1) (NN %))
                            (NNP SDS))
                          (, ,)
                          (NP
                            (ADJP
                              (QP (CD 100) (CD µg)))
                            (PRN (: /)
                              (NP
                                (NP (NN ml) (JJ phenylmethylsulfonyl) (NN fluoride))
                                (, ,)
                                (NP (CD 10) (NN µl)))
                              (: /))
                            (NN ml) (NNS protease-inhibitory-mix)))
                        (, ,)
                        (NP
                          (NP (CD 1) (JJ µmol) (JJ /) (NN ml) (NN sodiumorthovanadate))
                          (PP (IN in)
                            (NP (JJ phosphate-buffered) (NN saline)))))
                      (-RRB- -RRB-)))
                  (PP (IN for)
                    (NP
                      (NP (CD 30) (NN min))
                      (PP (IN on)
                        (NP (NN ice))))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN After)
      (NP (NN centrifugation)))
    (, ,)
    (NP
      (NP (NN protein) (NN concentration))
      (PP (IN of)
        (NP (DT the) (NN supernatant))))
    (VP (VBD was)
      (VP (VBN determined)
        (PP (IN by)
          (NP
            (NP (NNP BCA-method))
            (PRN (-LRB- -LRB-)
              (NP (NNP Pierce))
              (, ,)
              (NP (NNP Rockford))
              (, ,)
              (NP (NNP IL))
              (-RRB- -RRB-))
            (SBAR (IN as)
              (S
                (VP (VBD recommended))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NN Protein) (NNS lysates))
      (PRN (-LRB- -LRB-)
        (NP
          (NP (CD 70))
          (: --)
          (NP (CD 100) (NN µg)))
        (-RRB- -RRB-)))
    (VP (VBD were)
      (VP
        (VP (VBN electrophoresed)
          (PP (IN on)
            (NP (JJ polyacrylamide) (NNS gels))))
        (CC and)
        (VP (VBN transferred)
          (PP (TO to)
            (NP
              (NP (DT a) (NN PVDF-membrane))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (NNP Immobilon) (NNP P))
                  (, ,)
                  (NP (CD 0.45) (NN µm))
                  (, ;)
                  (NP (NNP Millipore))
                  (, ,)
                  (NP (NNP Eschborn))
                  (, ,)
                  (NP (NNP Germany)))
                (-RRB- -RRB-)))))))
    (. .)))

(ROOT
  (S
    (NP (NNS Membranes))
    (VP (VBD were)
      (VP
        (VP (VBN blocked)
          (PP (IN with)
            (NP
              (NP (CD 2.5) (NN %))
              (VP (VBG blocking)
                (NP
                  (NP
                    (NP (NN reagent))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP Boehringer) (NNP Mannheim))
                      (, ,)
                      (NP (NNP Germany))
                      (-RRB- -RRB-)))
                  (PP (IN in)
                    (NP
                      (NP (JJ TBST) (NN buffer))
                      (PRN (-LRB- -LRB-)
                        (NP
                          (NP
                            (QP (CD 4.44) (CD g/l))
                            (NNP Tris)
                            (PRN (: --)
                              (NP
                                (NP (NNP HCL))
                                (, ,)
                                (NP (CD 2.65) (NN g/l) (NNP TrisOH))
                                (, ,)
                                (NP (CD 8.07) (NN g/l) (NNP NaCl))
                                (, ,)
                                (NP (CD 0.2) (NN g/l) (NNP KCl))
                                (CC and)
                                (NP (CD 500) (NN µl)))
                              (: /))
                            (NNP l) (NN Tween-20))
                          (PP (IN in)
                            (NP (NNP H2O))))
                        (-RRB- -RRB-)))))))))
        (CC and)
        (ADVP (RB subsequently))
        (VP (VBN incubated)
          (PP (IN with)
            (NP
              (NP (JJ primary) (NN antibody))
              (PP (IN as)
                (NP
                  (NP (JJ indicated)
                    (CC and)
                    (JJ horseradish) (JJ peroxidase-conjugated) (JJ secondary) (NN antibody) (, ,) (NN anti-mouse)
                    (CC or)
                    (NN anti-goat) (NNS IgG))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP DAKO))
                    (, ,)
                    (NP (NNP Hamburg))
                    (, ,)
                    (NP (NNP Germany))
                    (-RRB- -RRB-))))))
          (, ,)
          (ADVP (RB respectively)))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NNS membranes))
    (VP (VBD were)
      (ADVP (RB then))
      (VP (VBN developed)
        (PP (IN with)
          (NP
            (NP (DT an) (NNP ECL) (NN detection) (NN kit))
            (PRN (-LRB- -LRB-)
              (NP (NNP Amersham) (NNP Pharmacia) (NNP Biotech))
              (, ,)
              (NP (NNP Freiburg))
              (, ,)
              (NP (NNP Germany))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (JJ primary) (NNS antibodies))
    (VP (VBD were)
      (VP (VBG goat)
        (NP
          (NP
            (NP
              (NP (JJ anti-IRF-4) (JJ /) (NN ICSAT))
              (PRN (-LRB- -LRB-)
                (NP (NNP M-17))
                (-RRB- -RRB-)))
            (PRN (-LRB- -LRB-)
              (NP (NNP Santa) (NNP Cruz) (NNP Biotechnology))
              (, ,)
              (NP (NNP Santa) (NNP Cruz))
              (, ,)
              (NP (NNP CA))
              (-RRB- -RRB-)))
          (CC and)
          (NP
            (NP
              (NP (NN mouse) (NN anti-β-actin))
              (PRN (-LRB- -LRB-)
                (NP (NNP AC-74))
                (-RRB- -RRB-)))
            (PRN (-LRB- -LRB-)
              (NP (NNP Sigma))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (NP (NNP DNA))
    (VP (VBD was)
      (VP (VBN extracted)
        (PP (IN with)
          (NP
            (NP (DT a) (JJ commercial) (NN kit))
            (PRN (-LRB- -LRB-)
              (NP (NNP Qiagen))
              (-RRB- -RRB-))
            (SBAR (IN as)
              (S
                (VP (VBD recommended))))))))
    (. .)))

(ROOT
  (S
    (SBAR (IN Since)
      (S
        (NP
          (NP (DT the) (NN restriction) (NN ability))
          (PP (IN of)
            (NP (JJ several) (NNS endonucleases))))
        (VP (VBZ is)
          (VP (VBN inhibited)
            (PP (IN by)
              (NP
                (NP (NN methylation))
                (PP (IN of)
                  (NP (PRP$ their) (NN target) (NN sequence)))))))))
    (, ,)
    (NP (PRP we))
    (VP (VBD used)
      (S
        (NP (JJ methylation-sensitive) (NNS enzymes))
        (NP
          (NP (NNP HpaII))
          (CC and)
          (NP
            (NP
              (NP (JJ HaeII-isochizomer) (NNS Bsp143II)
                (CC and)
                (NNS Bsh1236I))
              (PRN (-LRB- -LRB-)
                (NP (NNP MBI) (NNP Fermentas))
                (, ,)
                (NP (NNP St) (NNP Leon-Rot))
                (, ,)
                (NP (NNP Germany))
                (-RRB- -RRB-)))
            (PRN (-LRB- -LRB-)
              (NP (CD 20,24))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (PP (IN As)
      (NP (NN control)))
    (NP
      (NP
        (NP
          (NP (DT the) (JJ methylation-resistant) (NN enzyme))
          (NP (NNP MspI)))
        (CC and)
        (NP
          (NP (DT an) (NN enzyme))
          (PP (IN with)
            (NP
              (NP (DT no) (NN recognition) (NN site))
              (PP (IN in)
                (NP (DT the) (NN target) (NN promoter)))))))
      (, ,)
      (NP (NNP EcoRI))
      (, ,))
    (VP (VBD were)
      (VP (VBN used)))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP DNA))
      (PRN (-LRB- -LRB-)
        (NP
          (QP (CD 0.8) (CD µg)))
        (-RRB- -RRB-)))
    (VP (VBD was)
      (VP (VBN digested)
        (PP (IN by)
          (NP
            (NP (CD 40))
            (VP
              (VP (VBG U)
                (NP
                  (NP (DT the) (JJ respective) (NN enzyme))
                  (PP (IN for)
                    (NP (CD 6) (NN h)))))
              (CC and)
              (PRN (, ,)
                (S
                  (VP (TO to)
                    (VP (VB ensure)
                      (NP
                        (NP
                          (ADJP (JJ complete) (JJ cleavage))
                          (, ,) (JJ additional) (NNP 20) (NNP U))
                        (PP (IN for)
                          (NP
                            (NP (CD 16) (NN h.))
                            (SBAR
                              (S
                                (ADVP (RB Thereafter))
                                (NP
                                  (NP (CD 100) (NN ng))
                                  (PP (IN of)
                                    (NP (NNP digested) (NNP DNA))))
                                (VP (VBD was)
                                  (VP (VBN used)
                                    (PP (TO to)
                                      (NP
                                        (NP (DT a) (NNP PCR) (NN amplification))
                                        (PP (IN of)
                                          (NP
                                            (NP (CD two) (NNS fragments))
                                            (PRN (-LRB- -LRB-)
                                              (NP (NNP F1)
                                                (CC and)
                                                (NNP F2))
                                              (-RRB- -RRB-)))))))))))))))))
              (VP (VBG spanning)
                (NP
                  (NP (NN part))
                  (PP (IN of)
                    (NP
                      (NP (DT the) (NN IRF-4) (NN promoter))
                      (PRN (-LRB- -LRB-)
                        (NP (CD 30))
                        (-RRB- -RRB-)))))))
            (PRN (-LRB- -LRB-)
              (NP
                (NP (NNP GenBank))
                (SBAR
                  (S
                    (NP (NNP U52683))
                    (: ;)
                    (VP (VBP see)
                      (NP (NNP Figure) (CD 3A))))))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NNS sequences))
      (PP (IN of)
        (NP (DT the) (NNS primers))))
    (VP (VBD were)
      (NP
        (NP
          (NP
            (NP (NNS F1-forward))
            (: :)
            (NP
              (QP (CD 5) (CD ′))))
          (: -)
          (NP
            (NP (NNP TTGAGATGGAGTCTTGCTCTGT-3) (NNP ′))
            (, ,)
            (NP (NNS F1-reverse)))
          (: :)
          (NP
            (NP (NNP ATCACTTCCAGACTTCAGTTCACCT-3) (NNP ′))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 341) (CD bp)))
              (-RRB- -RRB-)))
          (: ;)
          (NP
            (NP (NNS F2-forward))
            (: :)
            (NP
              (QP (CD 5) (CD ′))))
          (: -)
          (NP
            (NP (NNP AAGGTGAACTGAAGTCTGGAAGTGA-3) (NNP ′))
            (, ,)
            (NP (NNS F2-reverse)))
          (: :)
          (NP
            (NP (CD 5) (NNS ′))
            (: -)
            (NP (NNP CCAGGACCTCAGGAGGCCAGTCA-3) (NNP ′))))
        (PRN (-LRB- -LRB-)
          (NP
            (QP (CD 474) (CD bp)))
          (-RRB- -RRB-))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NNP PCR) (NNS conditions))
    (VP (VBD were)
      (VP (VBN described)
        (ADVP (RB elsewhere))
        (PRN (-LRB- -LRB-)
          (NP (CD 3))
          (-RRB- -RRB-))))
    (. .)))

(ROOT
  (S
    (NP (NNP PCR))
    (VP (VBD was)
      (VP (VBN performed)
        (PP (IN with)
          (NP
            (NP (DT an) (VBG annealing) (NN temperature))
            (PP (IN of)
              (NP
                (NP (CD 62) (NNP °) (NNP C))
                (CC and)
                (NP (CD 35) (NNS cycles))))))))
    (. .)))

(ROOT
  (S
    (S
      (SBAR
        (WHADVP (WRB When))
        (S
          (NP (NNP DNA))
          (VP (VBD was)
            (VP (VBN methylated)
              (PP (IN at)
                (NP (JJ specific) (NNS sites)))))))
      (, ,)
      (NP (DT the) (JJ sensitive) (NNS enzymes))
      (VP (VBD were) (RB not)
        (ADJP (JJ able)
          (S
            (VP (TO to)
              (VP (VB digest)
                (NP (DT the) (NN DNA))))))))
    (CC and)
    (S
      (NP (NN amplification))
      (VP (VBD took)
        (NP (NN place))))
    (: ;)
    (S
      (PP (IN in)
        (NP
          (NP (NN case))
          (PP (IN of)
            (NP (DT no) (NN methylation)))))
      (, ,)
      (NP (NNP DNA))
      (VP (VBD was)
        (VP (VBN digested))))
    (CC and)
    (S
      (NP (DT no) (NN product))
      (VP (VBD was)
        (VP (VBN generated))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NNP PCR) (NNS products))
    (VP
      (VP (VBD were)
        (VP (VBN electrophoresed)
          (PP (IN on)
            (NP (DT a)
              (ADJP (CD 3) (NN %))
              (NN agarose) (NN gel)))))
      (, ,)
      (VP (VBD were)
        (VP (VBN stained)
          (PP (IN with)
            (NP (NN ethidium) (NN bromide)))))
      (CC and)
      (VP (VBD photographed)))
    (. .)))

(ROOT
  (S
    (NP (NNP PCR) (NNS products))
    (VP (VBD were)
      (VP (VBN verified)
        (PP (IN by)
          (NP (VBN automated) (NN sequencing)))))
    (. .)))

(ROOT
  (S
    (NP (NNP DNA))
    (VP (VBD was)
      (VP (VBN extracted)
        (SBAR (IN as)
          (S
            (VP (VBD described)
              (ADVP (RB above)))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ Bisulfite) (NN treatment))
      (PP (IN of)
        (NP (NNP DNA))))
    (, ,)
    (S
      (VP (VBG leading)
        (PP (TO to)
          (NP
            (NP (NN conversion))
            (PP (IN of)
              (NP (JJ unmethylated) (NN cytosine)))))
        (PP (TO to)
          (NP
            (NP (JJ uracil) (NNS residues))
            (CC and)
            (NP
              (NP (DT no) (NN change))
              (PP (IN of)
                (NP (JJ methylated) (NN cytosine) (NNS residues))))))))
    (, ,)
    (VP (VBD was)
      (VP (VBN performed)
        (SBAR (IN as)
          (S
            (VP (VBD described)
              (SBAR (IN as)
                (S
                  (VP (VBZ follows)))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Briefly))
    (, ,)
    (NP
      (NP
        (NP (CD 1) (NN µg))
        (PP (IN of)
          (NP (NNP DNA))))
      (CC and)
      (NP
        (NP (CD 2) (NN µg))
        (PP (IN of)
          (NP
            (NP
              (NP (NN poly))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (NN dA))
                  (: --)
                  (NP (NN dT)))
                (-RRB- -RRB-)))
            (PRN (-LRB- -LRB-)
              (NP
                (NP (NNP poly) (-LRB- -LRB-) (NNP dA))
                (: --)
                (NP (NN dT)))
              (-RRB- -RRB-))))))
    (VP (VBZ copolymers)
      (SBAR
        (S (-LRB- -LRB-)
          (NP (NNP Amersham) (NNP Pharmacia) (NNP Biotech))
          (-RRB- -RRB-)
          (VP (VBD were)
            (VP (VBN denaturated)
              (PP (IN for)
                (NP (CD 20) (NN min)))
              (PP (IN at)
                (NP
                  (NP (CD 42) (NNP °) (NNP C))
                  (PP (IN in)
                    (NP
                      (NP (CD 0.3) (NNP M) (NNP NaOH))
                      (PP (IN in)
                        (NP
                          (NP (DT a) (NN volume))
                          (PP (IN of)
                            (NP (CD 50) (NN µl))))))))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP
        (NP (JJ Fresh) (NNS solutions))
        (PP (IN of)
          (NP
            (NP
              (NP (CD 30) (NN µl))
              (PP (IN of)
                (NP
                  (NP (CD 10) (NN mM) (NN hydrochinon))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP Sigma))
                    (-RRB- -RRB-)))))
            (CC and)
            (NP
              (NP
                (QP (CD 530) (CD µl)))
              (PP (IN of)
                (NP
                  (NP (CD 3) (NNP M) (NN sodium) (NN bisulfite))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (NN pH) (CD 5.0))
                      (: ;)
                      (NP (NNP Sigma)))
                    (-RRB- -RRB-))))))))
      (VP (VBD were)
        (VP (VBN added))))
    (, ,)
    (NP (DT the) (NN solution))
    (VP
      (VP (VBD was)
        (ADVP (RB gently))
        (ADJP (JJ mixed)))
      (, ,)
      (VP (VBD overlayed)
        (PP (IN with)
          (NP (NN mineral) (NN oil))))
      (CC and)
      (VP (VBD incubated)
        (PP (IN in)
          (NP (DT the) (NN dark)))
        (PP (IN for)
          (NP (CD 12)))
        (PRN (: --)
          (S
            (NP
              (NP (CD 13) (NN h))
              (PP (IN at)
                (NP (CD 50))))
            (NP (NNP °) (NNP C))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NNS aqueous) (NN phase))
    (VP (VBD was)
      (VP (VBN recovered)
        (S
          (VP (VBG using)
            (NP
              (NP (DT the) (`` `) (JJ Wizard) (NN DNA) (JJ clean-up) (NN system) ('' '))
              (PRN (-LRB- -LRB-)
                (NP (NNP Promega))
                (, ,)
                (NP (NNP Mannheim))
                (, ,)
                (NP (NNP Germany))
                (-RRB- -RRB-)))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NNP purified) (NNP DNA))
    (VP (VBD was)
      (ADVP (RB subsequently))
      (VP
        (VP
          (ADJP (JJ mixed))
          (PP (IN with)
            (NP
              (NP (CD 1) (NNP M) (NNP NaOH))
              (PP (TO to)
                (NP
                  (NP (DT a) (JJ final) (NN concentration))
                  (PP (IN of)
                    (NP (CD 0.3) (NNS M))))))))
        (CC and)
        (VP (VBN incubated)
          (PP (IN for)
            (NP
              (NP (CD 20) (NN min))
              (PP (IN at)
                (NP (CD 37))))))
        (NP
          (NP (NNP °) (NNP C))
          (SBAR
            (S
              (VP (TO to)
                (VP (VB ensure)
                  (NP (JJ complete) (NN desulfonisation)))))))))
    (. .)))

(ROOT
  (S
    (NP (NNP DNA))
    (VP (VBD was)
      (NP
        (NP (NN ethanol) (NNS precipitated))
        (PP (IN in)
          (NP
            (NP (DT the) (NN presence))
            (PP (IN of)
              (NP
                (NP (CD 1/10) (NN vol))
                (PP (IN of)
                  (NP
                    (NP (CD 3) (NNP M) (NN sodium) (NN acetate))
                    (, ,)
                    (VP
                      (VP (VBN washed)
                        (PP (IN with)
                          (NP
                            (ADJP (CD 70) (NN %))
                            (NN ethanol))))
                      (CC and)
                      (VP (VBN resuspended)
                        (PP (IN in)
                          (NP (CD 50) (NN µl) (NN H2O)))))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ Subsequent) (NN PCR) (NN amplification))
      (PP (IN of)
        (NP (CD 4) (JJ µl) (JJ bisulfite-treated) (NN DNA))))
    (VP (VBD was)
      (VP (VBN used)
        (PP (IN for)
          (S
            (VP (VBG cloning)
              (PP (IN of)
                (NP
                  (NP (CD two) (NNS fragments))
                  (PP (IN of)
                    (NP
                      (NP (DT the) (NN IRF-4) (NN promoter))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP BS-I)
                          (CC and)
                          (NNP BS-II))
                        (-RRB- -RRB-))))))
              (PP (IN into)
                (NP
                  (NP (CD pCR2) (CD .1) (NN vector))
                  (PP (IN with)
                    (NP
                      (NP (DT the) (`` `) (NNP TOPO) (NNP TA) (NN cloning) (NN kit) ('' '))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP Invitrogen))
                        (-RRB- -RRB-))))))
              (PRN (-LRB- -LRB-)
                (S
                  (VP (VB see)
                    (NP (NNP Figure) (CD 3A))))
                (-RRB- -RRB-)))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NNS primers))
      (VP (VBN used)
        (PP (IN for)
          (NP
            (NP (NNP PCR) (NNP amplification))
            (PP (IN of)
              (NP (DT the) (NNP BS-I)
                (CC and)
                (NNP BS-II) (NNS fragments)))))))
    (VP (VBP contain)
      (NP
        (NP (DT the) (JJ putative) (JJ altered) (NN sequence))
        (PP (IN of)
          (NP
            (NP
              (NP
                (NP (DT the) (NN sense))
                (VP (VBN strand)
                  (ADJP (JJ due)
                    (S
                      (VP (TO to)
                        (VP (VB bisulfite)
                          (NP (NN treatment))))))))
              (PRN (-LRB- -LRB-)
                (S
                  (NP (JJ converted) (NN cytosine) (NNS residues))
                  (VP (VBP are)
                    (VP (VBN written)
                      (PP (IN in)
                        (NP (JJ bold) (NNS letters))))))
                (-RRB- -RRB-)))
            (: :)
            (NP
              (NP
                (NP (NNP BS-I-forward))
                (NP (CD 5) (NNS ′)))
              (: -)
              (NP
                (NP (NNP TATTTGGATTTTTAGGGAGTTTTTTTT-3) (NNP ′))
                (, ,)
                (NP (JJ BS-I-reverse) (CD 5) (NNS ′)))
              (: -)
              (NP
                (NP
                  (NP (NNP ACCCAACTCCCTTAAACTATTAAACT-3) (NNP ′))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (QP (CD 187) (CD bp)))
                    (-RRB- -RRB-)))
                (: ;)
                (NP
                  (ADJP (JJ BS-II-forward)
                    (NP (CD 5)))
                  (NNS ′)))
              (: -)
              (NP
                (NP (NNP AGTTTAATAGTTTAAGGGAGTTGGGT-3) (NNP ′))
                (, ,)
                (NP (JJ BS-II-reverse) (CD 5) (NNS ′)))
              (: -)
              (NP
                (NP (NNP CTCACCCTAAACTCAAAACTAAAAAC-3) (NNP ′))
                (PRN (-LRB- -LRB-)
                  (NP
                    (QP (CD 674) (CD bp)))
                  (-RRB- -RRB-))))))))
    (. .)))

(ROOT
  (S
    (SBAR (IN After)
      (S
        (NP
          (NP (JJ bacterial) (NN amplification))
          (PP (IN of)
            (NP (DT the) (NNP cloned) (NNP PCR))))
        (VP (VBZ fragments)
          (PP (IN by)
            (NP (JJ standard) (NNS procedures))))))
    (, ,)
    (NP
      (NP (CD eight) (NNS clones))
      (PP (IN from)
        (NP (DT each) (NN sample))))
    (VP (VBD were)
      (VP (VBN sequenced)
        (PP (IN with)
          (NP
            (NP (DT an) (VBN automated) (NN sequencer))
            (PRN (-LRB- -LRB-)
              (NP
                (NP (NNP ABI) (NNP Prism) (NNP 377))
                (, ,)
                (NP (NNP Applied) (NNP Biosystems)))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NNP IRF-4) (NN promoter-reporter) (NN gene) (NN construct))
    (VP (VBD was)
      (ADVP (RB generously))
      (VP (VBN provided)
        (PP (IN by)
          (NP
            (NP (NNP J.) (NNP Hiscott))
            (PRN (-LRB- -LRB-)
              (NP (CD 31))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (NP (NNS Constructs))
    (VP (VBD were)
      (VP (VBN methylated)
        (PP (IN in)
          (ADJP (NN vitro)
            (PP (IN with)
              (NP
                (NP (NNP CpG) (NNP Methylase))
                (PRN (-LRB- -LRB-)
                  (NP (NNP M.Sss) (NNP I))
                  (-RRB- -RRB-))))))
        (SBAR (IN as)
          (S
            (S
              (VP (VBN recommended)
                (PP (IN by)
                  (NP
                    (NP
                      (NP (DT the) (NN manufacturer))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP NE) (NNP Biolabs))
                        (-RRB- -RRB-)))
                    (CC and)
                    (NP (JJ complete) (NN methylation))))))
            (VP (VBD was)
              (VP (VBN checked)
                (PP (IN via)
                  (NP
                    (NP (NN restriction) (NN analysis))
                    (PRN (-LRB- -LRB-)
                      (NP (NN Figure) (CD 5A))
                      (-RRB- -RRB-))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ Reporter) (NN gene) (NNS assays))
      (VP (VBG using)
        (NP
          (NP (DT the) (JJ dual) (NN luciferase) (NN assay))
          (PRN (-LRB- -LRB-)
            (NP (NNP Promega))
            (-RRB- -RRB-)))))
    (VP (VBD were)
      (VP (VBN performed)
        (ADJP (JJ similar))
        (PP (TO to)
          (NP
            (NP (JJ previous) (NNS reports))
            (PRN (-LRB- -LRB-)
              (NP (CD 29))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Briefly))
    (, ,)
    (NP
      (NP (CD 5) (NN nM))
      (PP (IN of)
        (NP
          (NP (DT the) (NN reporter) (NN construct))
          (CC and)
          (NP (DT the) (NN transfection) (NN control)))))
    (VP (VB construct)
      (S
        (VP (VBG expressing)
          (SBAR
            (S
              (NP (DT the) (NN renilla) (NN luciferase) (NN gene))
              (VP (VBD were)
                (VP (VBN transientlyco-expressed)
                  (PP (IN via)
                    (NP (NN electroporation))))))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NN control))
    (VP (VB construct)
      (VP (VBN served)
        (PP (IN as)
          (NP
            (NP (DT an) (JJ internal) (NN reference))
            (PP (IN for)
              (NP (NN transfection) (NN efficiency)))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ Forty-eight) (NNS hours))
      (PP (IN after)
        (NP (JJ transfection) (, ,) (JJ luciferase) (NN activity))))
    (VP (VBD was)
      (VP (VBN measured)
        (PP (IN with)
          (NP
            (NP (DT a) (NNP LB) (CD 96) (NNP P) (NN microlumat))
            (PRN (-LRB- -LRB-)
              (NP (NNP EG&G) (NNP Berthold))
              (, ,)
              (NP (NNP Bad) (NNP Wildbad))
              (, ,)
              (NP (NNP Germany))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (NP (NN IRF-4) (NN promoter) (NN activation))
    (VP (VBD was)
      (VP (VBN quantified)
        (PP (IN as)
          (NP
            (NP
              (NP (DT a) (NN ratio))
              (PP (IN of)
                (NP
                  (NP (JJ measured)
                    (ADJP (RB firefly) (JJ light))
                    (NNS units))
                  (PRN (-LRB- -LRB-)
                    (NP (NN flu))
                    (-RRB- -RRB-))))
              (ADVP (JJ relative)
                (PP (TO to)
                  (NP (NN renilla)))))
            (PRN (-LRB- -LRB-)
              (NP (NN rlu))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (NP (DT Each) (NN experiment))
    (VP (VBD was)
      (VP (VBN carried)
        (PP (IN out)
          (NP
            (QP (IN at) (JJS least) (CD three) (NNS times))))))
    (. .)))

(ROOT
  (S
    (NP (NNP RESULTS) (PRP We))
    (VP (VBP have)
      (ADVP (RB previously))
      (VP (VBN demonstrated)
        (NP
          (NP (DT a) (NN lack))
          (PP (IN of)
            (NP (NN IRF-4) (NN expression))))
        (PP
          (PP (IN in)
            (NP (NN leukemia) (NNS patients)))
          (CC and)
          (ADVP (RB specifically))
          (PP (IN in)
            (NP
              (NP (NNP CML) (NNP T-cells))
              (PRN (-LRB- -LRB-)
                (NP (CD 3))
                (-RRB- -RRB-)))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Here))
    (, ,)
    (NP (PRP we))
    (VP (VBP demonstrate)
      (NP
        (NP (DT the) (NN absence))
        (PP (IN of)
          (NP
            (NP (NN IRF-4) (NN expression))
            (PP (IN in)
              (NP
                (NP (JJ various) (JJ hematopoietic) (NN cell) (NNS lines))
                (, ,)
                (PP (JJ such) (IN as)
                  (NP (NNP Jurkat)))
                (, ,))))))
      (UCP
        (NP
          (NP (DT a) (JJ T-cell) (NN leukemia))
          (, ,)
          (NP (NN CML-T1))
          (, ,)
          (NP (DT a) (JJ bcr-abl-positive) (JJ T-cell) (NN line))
          (, ,)
          (NP (NN K-562))
          (, ,)
          (NP (DT a) (JJ bcr-abl-positve) (NN erythroleukemia))
          (, ,)
          (NP (NN U-937))
          (, ,)
          (NP (DT a) (JJ monocytic) (NN leukemia))
          (, ,)
          (NP (NN EM-2)
            (CC and)
            (NN LAMA-84))
          (, ,)
          (NP (JJ bcr-abl-positve) (JJ myeloid) (NN leukemia)))
        (, ,)
        (CC but)
        (PP (RB not) (IN in)
          (NP
            (NP (NN SD-1))
            (, ,)
            (NP (DT a) (JJ bcr-abl-positive) (JJ acute) (JJ lymphoblastic) (NN leukemia))
            (PRN (-LRB- -LRB-)
              (NP (NNP pre) (NNP B-ALL))
              (-RRB- -RRB-))
            (, ,)
            (NP (NN RPMI-8226))
            (, ,)
            (NP (DT a) (JJ multiple) (NN myeloma))
            (CC and)
            (NP
              (NP (NN BV-173))
              (, ,)
              (NP
                (NP (DT a) (JJ bcr-abl-positive) (JJ B-cell) (NN line))
                (-LRB- -LRB-)
                (NP (NNS Figures) (CD 1A)
                  (CC and)
                  (CD 5D))
                (-RRB- -RRB-)))))))
    (. .)))

(ROOT
  (S
    (PP (IN After)
      (S
        (VP (VBG sequencing)
          (PP (IN of)
            (NP (DT the) (NN IRF-4) (NN promoter))))))
    (, ,)
    (NP (PRP it))
    (VP (MD could)
      (VP (VB be)
        (VP (VBN excluded)
          (SBAR (IN that)
            (S
              (NP
                (NP (NN absence))
                (PP (IN of)
                  (NP
                    (NP (NN IRF-4) (NN expression))
                    (PP (IN in)
                      (NP
                        (NP (DT any))
                        (PP (IN of)
                          (NP (DT the) (JJ above) (NN cell) (NNS lines))))))))
              (VP (VBD was)
                (ADJP (JJ due)
                  (PP (TO to)
                    (NP (JJ genetic) (NNS aberrations))))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP
      (NP (CD 2) (NN bp) (NNS changes))
      (PRN (-LRB- -LRB-)
        (NP
          (NP (JJ nucleotide) (JJ −) (NNS 1081))
          (, ,)
          (NP (NNP T) (NNP →) (NNP C)
            (CC and)
            (NNP −) (NNP 1068))
          (, ,)
          (NP (DT A) (NNP →) (NNP C)))
        (-RRB- -RRB-)))
    (VP (MD could)
      (VP (VB be)
        (VP (VBN detected)
          (PP (IN in)
            (NP (CC both)
              (NP (DT the) (NN IRF-4-positive) (NN BV-173))
              (CC and)
              (NP
                (NP
                  (NP (DT the) (NN IRF-4-negative))
                  (ADJP (JJ LAMA-84) (, ,) (JJ EM-2)
                    (CC and)
                    (JJ K-562)))
                (PRN (-LRB- -LRB-)
                  (NP (NN Figure) (CD 1B))
                  (-RRB- -RRB-))))))))
    (. .)))

(ROOT
  (S
    (PP (IN At)
      (NP (NN position) (NNP −) (NNP 116)))
    (NP (DT an) (NNP A) (NNP →) (NNP C) (NN substitution))
    (VP (VBD was)
      (VP (VBN found)
        (PP (IN in)
          (NP (NNP EM-2) (, ,) (NNP K-562)
            (CC and)
            (NNP CML-T1)))
        (, ,)
        (SBAR (IN whereas)
          (S
            (NP (NNP Jurkat) (, ,) (NNP BV-173)
              (CC and)
              (NNP SD-1))
            (VP (VBD exhibited)
              (NP
                (NP (DT a) (VBN mixed) (NNP A/C) (NN sequence))
                (CC and)
                (NP
                  (NP
                    (ADJP (JJ U-937) (, ,) (JJ LAMA-84)
                      (CC and)
                      (JJ RPMI-8226))
                    (DT no) (NN substitution))
                  (PP (IN at)
                    (NP
                      (NP (DT all))
                      (PRN (-LRB- -LRB-)
                        (NP (NN Figure) (CD 1B))
                        (-RRB- -RRB-)))))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Consequently))
    (, ,)
    (NP (DT these) (NNS alterations))
    (VP (VBP are)
      (ADJP (JJ unlikely)
        (S
          (VP (TO to)
            (VP (VB affect)
              (NP (NN IRF-4) (NN expression)))))))
    (. .)))

(ROOT
  (S
    (NP (PRP We))
    (ADVP (RB next))
    (VP (VBD analyzed)
      (SBAR (IN whether)
        (S
          (NP (NN promoter) (NN methylation))
          (VP (MD could)
            (VP (VB be)
              (ADJP (JJ responsible)
                (PP (IN for)
                  (NP
                    (NP (NN down-regulation))
                    (PP (IN of)
                      (NP (NN IRF-4) (NN expression)))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT A) (NN region))
      (PP (VBG including)
        (NP
          (NP (NNS exon1))
          (PP (IN in)
            (NP (DT the) (NN IRF-4) (NN promoter))))))
    (VP (VBD exhibited)
      (NP
        (NP (DT a) (JJ large) (NN number))
        (PP (IN of)
          (NP
            (NP (JJ CpG-rich) (NNS sequences))
            (PRN (-LRB- -LRB-)
              (NP (NN Figure) (CD 3A))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ Several) (NN chemical) (NNS substances))
      (PP (JJ such) (IN as)
        (NP
          (NP (JJ 5-aza-2-deoxycytidine))
          (PRN (-LRB- -LRB-)
            (NP (NNP AzadC))
            (-RRB- -RRB-))
          (CC or)
          (NP (JJ 5-azacytidine))
          (PRN (-LRB- -LRB-)
            (NP (NNP AzaC))
            (-RRB- -RRB-)))))
    (VP
      (VP (VBP inhibit)
        (NP (NNP de) (NN novo)
          (CC and)
          (NN maintenance) (NNS methylation)))
      (, ,)
      (CC and)
      (VP
        (ADVP (RB thus))
        (MD can)
        (VP (VB be)
          (VP (VBN used)
            (S
              (VP (TO to)
                (VP (VB discern)
                  (NP
                    (NP (NN promoter) (NN methylation))
                    (PRN (-LRB- -LRB-)
                      (NP (CD 32,33))
                      (-RRB- -RRB-))))))))))
    (. .)))

(ROOT
  (S
    (NP (PRP We))
    (VP (VBD used)
      (S
        (NP (NNP AzadC))
        (VP (TO to)
          (VP (VB generate)
            (NP (JJ unmethylated) (NN DNA))))))
    (. .)))

(ROOT
  (S
    (NP (DT A) (CD 72) (NN h) (NN AzadC-treatment))
    (VP (VBD resulted)
      (PP (IN in)
        (NP
          (NP (DT a) (JJ concentration-dependent) (NN activation))
          (PP (IN of)
            (NP (NN IRF-4) (NN transcription)))))
      (PP
        (PP (IN in)
          (NP (NNP Jurkat)
            (CC and)
            (NNP CML-T1) (NNPS T-cells)))
        (CONJP (RB as) (RB well) (IN as))
        (PP (IN in)
          (NP
            (NP
              (ADJP (JJ U-937) (, ,) (JJ K-562)
                (CC and)
                (JJ EM-2))
              (NN cell) (NNS lines))
            (PRN (-LRB- -LRB-)
              (NP (NN Figure) (CD 2A))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (NP (NN IRF-4) (NN transcription))
    (VP
      (VP (VBD was)
        (VP (VBN induced)
          (PP (IN in)
            (NP (DT a) (JJ time-dependent) (NN manner)))))
      (CC and)
      (VP (VBD was)
        (VP
          (VP (VBN observed)
            (ADVP (RB as) (RB early))
            (PP (IN as)
              (NP (CD 24) (NN h)))
            (PP (IN after)
              (NP
                (NP (NN treatment))
                (PP (IN with)
                  (NP (NNP AzadC))))))
          (CC and)
          (VP (VBN increased)
            (PP (IN over)
              (NP (NN time)))
            (PP (IN until)
              (NP
                (NP (CD 72) (NN h))
                (PRN (-LRB- -LRB-)
                  (NP (NN Figure) (CD 2B))
                  (-RRB- -RRB-))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP
        (NP (NN Time)
          (CC and)
          (NN strength))
        (PP (IN of)
          (NP
            (NP (DT the) (NN appearance))
            (PP (IN of)
              (NP (NN IRF-4) (NNS transcripts))))))
      (VP (VBD varied)
        (PP (IN among)
          (NP (NN cell) (NNS lines)))))
    (, ,)
    (NP (NNP i.e.) (NNP CML-T1))
    (VP (VBD responded)
      (NP
        (NP (JJS strongest))
        (PP (TO to)
          (NP
            (NP (NNP AzadC-treatment))
            (PRN (-LRB- -LRB-)
              (NP
                (NP (NNS data))
                (VP (RB not) (VBN shown)))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP (NN line))
        (PP (IN with)
          (NP (DT this)))))
    (, ,)
    (NP
      (NP (NNP AzadC-treatment))
      (PP (IN of)
        (NP (NN CML-T1)
          (CC and)
          (NN LAMA-84) (NNS cells))))
    (ADVP (RB also))
    (VP (VBN translated)
      (PP (IN in)
        (NP
          (NP (DT an) (NN induction))
          (PP (IN of)
            (NP
              (NP (NN IRF-4) (NN protein) (NN expression))
              (PRN (-LRB- -LRB-)
                (NP (NN Figure) (CD 2C))
                (-RRB- -RRB-)))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Accordingly))
    (, ,)
    (NP
      (NP (NN treatment))
      (PP (IN of)
        (NP
          (NP (DT the) (NN IRF-4-positive) (NN cell) (NN line))
          (ADJP (JJ BV-173) (, ,) (JJ SD-1)
            (CC and)
            (JJ RPMI-8226))
          (PP (IN with)
            (NP (NNP AzadC))))))
    (VP (VBD had)
      (NP
        (NP (DT no) (NN effect))
        (PP (IN on)
          (NP
            (NP (NN IRF-4) (NN expression))
            (PRN (-LRB- -LRB-)
              (NP (NN Figure) (CD 2D))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (NP (EX There))
    (VP (VBD was)
      (NP
        (NP (DT no) (NN difference))
        (PP (IN in)
          (NP
            (NP (DT the) (NNS effects))
            (PP (IN of)
              (NP (NNP AzaC)
                (CC versus)
                (NNP AzadC))))))
      (, ,)
      (SBAR (IN as)
        (S
          (NP (DT both))
          (VP (VBD increased)
            (NP
              (NP (DT the) (NN IRF-4) (NN mRNA) (NN level))
              (PP (IN in)
                (NP (NN CML-T1) (NNS cells))))
            (ADVP
              (ADVP (RB as) (RB well))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (NNS data))
                  (VP (RB not) (VBN shown)))
                (-RRB- -RRB-)))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (DT This))
      (VP (VBD implied)
        (SBAR (IN that)
          (S
            (NP (NN promoter) (NN methylation))
            (VP (MD may)
              (VP (VB control)
                (NP (NN IRF-4) (NN expression))))))))
    (, ,)
    (CC but)
    (S
      (NP (DT an) (JJ alternative) (NN explanation))
      (VP (MD may)
        (VP (VB be)
          (VP (VBN activation)
            (PP (IN of)
              (NP
                (NP (JJ positive) (JJ transcriptional) (NNS regulators))
                (PP (IN of)
                  (NP (NN IRF-4)))))
            (PP (IN by)
              (NP
                (NP (NNP AzadC))
                (PRN (-LRB- -LRB-)
                  (NP
                    (QP (CC or)
                      (CD AzaC)))
                  (-RRB- -RRB-))))))))
    (. .)))

(ROOT
  (S
    (S
      (VP (TO To)
        (VP
          (ADVP (RBR further))
          (VB investigate)
          (NP (NN promoter) (NN methylation))
          (PP (IN as)
            (NP
              (NP (DT a) (JJ regulatory) (NN mechanism))
              (PP (IN of)
                (NP (NN IRF-4) (NN gene) (NN expression))))))))
    (, ,)
    (NP (NNS restriction-PCR-assays))
    (VP (VBD were)
      (VP
        (VP (VBN performed)
          (PRN (-LRB- -LRB-)
            (NP (CD 20,24))
            (-RRB- -RRB-)))
        (, ,)
        (SBAR
          (WHADVP (WRB where))
          (S
            (NP (RB only) (JJ methylated) (NN DNA))
            (VP (MD would) (RB not)
              (VP (VB be)
                (VP (VBN cut)
                  (S
                    (VP (VBG enabling)
                      (NP (JJ subsequent) (NNP PCR) (NN amplification)
                        (CC and)
                        (NN vice) (NNS versa)))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Genomic) (NNP DNA))
      (PP (IN from)
        (NP
          (NP (JJ leukemic) (NNS cells))
          (ADJP (JJ Jurkat) (, ,) (JJ CML-T1) (, ,) (JJ U-937) (, ,) (JJ K-562) (, ,) (JJ EM-2)
            (CC and)
            (JJ BV-173)))))
    (VP (VBD was)
      (VP (VBN digested)
        (PP (IN with)
          (NP
            (NP (DT the) (JJ methylation-sensitive) (NNP enzymes) (NNP HpaII))
            (, ,)
            (NP (NNS Bsh1236I))
            (CC and)
            (NP (JJ HaeII-isochizomer) (NNS Bsp143II))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP EcoRI))
      (, ,)
      (SBAR
        (WHNP (WDT which))
        (S
          (VP (VBZ has)
            (NP
              (NP
                (NP (DT no) (NN recognition) (NN site))
                (PP (IN within)
                  (NP (DT the) (NN IRF-4) (NN promoter))))
              (, ,)
              (CC and)
              (NP
                (NP (DT the) (JJ methylation-resistant) (NN enzyme))
                (NP (NNP MspI))))))))
    (VP (VBD served)
      (PP (IN as)
        (NP (NNS controls))))
    (. .)))

(ROOT
  (S
    (NP (CD Two) (JJ separate) (NN amplification) (NNS reactions))
    (VP (VBD were)
      (VP (VBN performed) (, ,)
        (S
          (VP (VBG generating)
            (NP
              (NP (CD two) (NNS fragments))
              (, ,)
              (NP (NNP F1)
                (CC and)
                (NNP F2))
              (PRN (-LRB- -LRB-)
                (NP (NN Figure) (CD 3A))
                (-RRB- -RRB-)))))))
    (. .)))

(ROOT
  (S
    (PP (IN After)
      (NP
        (NP (NN digestion))
        (PP (IN with)
          (NP (NNP HpaII)
            (CC and)
            (NNP Bsp143II)))))
    (NP
      (NP (DT a) (JJ sufficient) (NNP PCR) (NN amplification))
      (PP (IN of)
        (NP (NNP F1)
          (CC and)
          (NNP F2))))
    (VP (VBD was)
      (VP (VBN detected)
        (PP (IN in)
          (NP (NNP DNA)))
        (PP (IN from)
          (S
            (NP
              (NP (NNP IRF-4-negative) (NNP Jurkat))
              (, ,)
              (NP
                (ADJP (JJ CML-T1) (, ,) (JJ U-937) (, ,) (JJ K-562)
                  (CC and)
                  (JJ EM-2))
                (NNS cells))
              (, ,))
            (VP (VBG suggesting)
              (NP
                (NP (DT a) (NN promoter) (NN methylation))
                (PRN (-LRB- -LRB-)
                  (CC and)
                  (NP
                    (NP (NN restriction))
                    (NP (NN protection)))
                  (-RRB- -RRB-)))
              (PP (IN at)
                (NP
                  (NP (DT the) (JJ respective) (NN recognition) (NNS sites))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (NNP Figure) (CD 3B))
                      (CC and)
                      (NP (NNP C)))
                    (-RRB- -RRB-)))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Notably))
    (, ,)
    (PP (IN in)
      (NP (NN IRF-4-positive) (NN SD-1) (NNS cells)))
    (NP
      (NP (NN digestion))
      (PP (IN with)
        (NP (DT the) (JJ methylation-sensitive) (NNS enzymes))))
    (VP
      (ADVP (RB completely))
      (VBD inhibited)
      (NP
        (NP (NN amplification))
        (PP (IN of)
          (NP (NNP F1)
            (CC and)
            (NNP F2)))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (NN IRF-4-positive) (NN BV-173) (NNS cells)))
    (NP
      (NP (DT a) (NNP HpaII))
      (, ,)
      (CONJP (CC but)
        (RB not))
      (NP (DT a) (JJ Bsh1236I) (NN digestion))
      (, ,))
    (VP
      (ADVP (RB significantly))
      (VBD reduced)
      (NP
        (NP (DT the) (JJ amplifiable) (NN DNA) (NN message))
        (PP (IN of)
          (NP
            (NP
              (NP (NNP F2))
              (PRN (-LRB- -LRB-)
                (NP (NN Figure) (CD 3C))
                (-RRB- -RRB-)))
            (, ,)
            (SBAR (IN whereas)
              (S
                (NP
                  (NP (NN amplification))
                  (PP (IN of)
                    (NP (NNP F1))))
                (VP (VBD was) (RB not)
                  (VP (VBN affected)))))))
        (PRN (-LRB- -LRB-)
          (NP (NN Figure) (CD 3B))
          (-RRB- -RRB-))))
    (. .)))

(ROOT
  (S
    (NP (DT This))
    (VP (VBD implied)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN IRF-4) (NN transcription))
            (PP (IN in)
              (NP (NN SD-1)
                (CC and)
                (NN BV-173) (NNS cells))))
          (VP (VBZ is)
            (VP (VBN associated)
              (PP (IN with)
                (NP (JJR less) (NN promoter) (NN methylation)))
              (PRN (-LRB- -LRB-)
                (PP (IN in)
                  (S
                    (VP (VBG BV-173)
                      (ADVP (RB especially))
                      (PP (IN at)
                        (NP (NNP HpaII) (NNS sites))))))
                (-RRB- -RRB-))
              (PP (IN as)
                (PP (VBN compared)
                  (PP (IN with)
                    (NP (DT the) (JJ tested) (NN IRF-4-negative) (NNS cells))))))))))
    (. .)))

(ROOT
  (S
    (SBAR (IN In) (NN order)
      (S
        (VP (TO to)
          (VP
            (ADVP (RB exactly))
            (VB map)
            (NP (DT the) (NN methylation) (NNS sites))
            (PP (IN within)
              (NP (DT the) (NN IRF-4) (NN promoter)))))))
    (, ,)
    (NP (PRP we))
    (VP (VBD treated)
      (NP
        (NP (NNP DNA))
        (PP (IN of)
          (NP (NN Jurkat) (, ,) (NN CML-T1) (, ,) (NN U-937) (, ,) (NN K-562)
            (CC and)
            (NN EM-2) (NNS cells))))
      (PP
        (CONJP (RB as) (RB well) (IN as))
        (IN of)
        (NP
          (NP
            (ADJP (JJ SD-1) (, ,) (JJ RPMI-8226)
              (CC and)
              (JJ BV-173))
            (NN control) (NNS cells))
          (PP (IN with)
            (NP (NN bisulfite)))
          (, ,)
          (SBAR
            (WHNP (WDT which))
            (S
              (VP
                (ADVP (RB chemically))
                (VBZ converts)
                (NP (JJ unmethylated) (NN cytosine)
                  (S
                    (VP (TO to)
                      (VP (VB uracil)))))
                (, ,)
                (SBAR (IN whereas)
                  (S
                    (NP (PRP it))
                    (VP (VBZ has)
                      (NP
                        (NP (DT no) (NN effect))
                        (PP (IN on)
                          (NP
                            (NP (JJ methylated) (NN cytosine))
                            (, ,)
                            (VP (VBN i.e.)
                              (PP (IN in)
                                (NP
                                  (NP (NNP CpG))
                                  (PRN (-LRB- -LRB-)
                                    (NP (CD 34))
                                    (-RRB- -RRB-)))))))))))))))))
    (. .)))

(ROOT
  (S
    (NP (DT This) (NN technique))
    (VP (VBZ is)
      (ADJP (RB especially) (JJ useful)
        (PP (IN for)
          (NP
            (NP (NN detection))
            (PP (IN of)
              (NP (JJ unknown) (NN methylation) (NNS patterns)))))))
    (. .)))

(ROOT
  (S
    (NP (NNP PCR) (NNP amplification))
    (, ,)
    (S
      (VP (VBG cloning)
        (CC and)
        (VBG sequencing)
        (PP (IN of)
          (NP (DT the) (JJ bisulfite-treated) (NN DNA)))))
    (VP (VBD showed)
      (NP
        (NP (DT a) (JJ specific) (NN methylation) (NN pattern))
        (PP (IN of)
          (NP
            (NP (DT the) (JJ analyzed) (CD 62) (NNP CpG) (NNS sites))
            (PP (IN in)
              (NP
                (NP (DT all) (NN cell) (NNS lines))
                (PRN (-LRB- -LRB-)
                  (NP
                    (QP (CD Figure) (CD 4)
                      (CC and)
                      (CD Table) (CD 1)))
                  (-RRB- -RRB-))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (NN general)))
    (, ,)
    (NP (DT the) (JJ methylational) (NN status))
    (VP (VBD ranged)
      (PP (IN from)
        (NP
          (NP (CD one) (NN cell) (NN line))
          (PP (IN with)
            (NP
              (NP (DT a)
                (ADJP (RB nearly) (JJ non-methylated))
                (NN IRF-4) (NN promoter))
              (PRN (-LRB- -LRB-)
                (NP (NNP SD-1))
                (, ,)
                (NP (NNP IRF-4-positive))
                (-RRB- -RRB-))))))
      (PP (TO to)
        (NP
          (NP (DT a)
            (ADJP (RB completely) (JJ methylated))
            (NN IRF-4) (NN promoter))
          (PP (IN in)
            (NP (NN CML-T1)))))
      (PRN (-LRB- -LRB-)
        (ADJP (JJ IRF-4-negative))
        (-RRB- -RRB-)))
    (. .)))

(ROOT
  (S
    (ADVP (RB Interestingly))
    (, ,)
    (NP
      (NP (DT the) (NN percentage))
      (PP (IN of)
        (NP
          (NP (NNP CpG) (NNP methylation))
          (PP (IN in)
            (NP
              (NP (DT the) (NN IRF-4) (NN promoter))
              (PP (IN from)
                (NP (NN IRF-4-positive) (NNS cells))))))))
    (VP (VBD was)
      (ADJP (RB very) (JJ low)
        (PRN (-LRB- -LRB-)
          (S
            (VP (VB mean)
              (NP (CD 24) (NN %))))
          (-RRB- -RRB-))
        (SBAR (IN as)
          (S
            (VP (VBN compared)
              (PP (IN with)
                (NP
                  (NP
                    (NP (NN IRF-4-negative) (NNS cells))
                    (PRN (-LRB- -LRB-)
                      (S
                        (VP (VB mean)
                          (NP (CD 94) (NN %))))
                      (-RRB- -RRB-)))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (NNP Figure) (CD 4A))
                      (CC and)
                      (NP (NNP Table) (CD 1)))
                    (-RRB- -RRB-)))))))))
    (. .)))

(ROOT
  (X
    (NP (DT A) (CD 5) (NNS ′))
    (: -)
    (S
      (NP
        (NP
          (NP (NN region))
          (PRN (-LRB- -LRB-)
            (NP (NNP R1))
            (-RRB- -RRB-)))
        (PP (IN with)
          (NP (CD 13))))
      (VP (VBD hypermethylated)
        (SBAR
          (S
            (S
              (NP (NNP CpG) (NNS sites))
              (PRN (-LRB- -LRB-)
                (VP (VB mean)
                  (NP
                    (NP (NN number))
                    (PP (IN of)
                      (NP (JJ methylated) (NNS clones))))
                  (PP
                    (NP
                      (QP (CD 5.5) (IN of) (CD 8)))
                    (IN with)
                    (NP
                      (ADJP (CD 77) (NN %))
                      (JJ methylated) (NNS CpGs))))
                (-RRB- -RRB-))
              (VP (VBD was)
                (VP (VBN found)
                  (PP (IN in)
                    (NP (JJS most) (NNS cells)))
                  (PRN (-LRB- -LRB-)
                    (PP (IN except)
                      (NP (NN SD-1)
                        (CC and)
                        (NN RPMI-8226)))
                    (-RRB- -RRB-)))))
            (CC and)
            (S
              (NP
                (NP (DT a) (CD 3) (NNS ′))
                (: -)
                (NP
                  (NP
                    (NP (NN region))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP R3))
                      (-RRB- -RRB-)))
                  (PP (IN of)
                    (NP
                      (NP (CD 6) (JJ hypomethylated) (NNP CpG) (NNS sites))
                      (PRN (-LRB- -LRB-)
                        (S
                          (VP (VB mean)
                            (NP
                              (NP (NN number))
                              (PP (IN of)
                                (NP (JJ methylated) (NNS clones))))
                            (PP
                              (NP
                                (QP (CD 1.7) (IN of) (CD 8)))
                              (IN with)
                              (NP
                                (ADJP (CD 33) (NN %))
                                (JJ methylated) (NNS CpGs)))))
                        (-RRB- -RRB-))))))
              (VP (VBD was)
                (VP (VBN found)
                  (PP (IN in)
                    (NP
                      (NP
                        (NP (JJS most) (NNS cells))
                        (PRN (-LRB- -LRB-)
                          (PP (IN except)
                            (NP (NN CML-T1)
                              (CC and)
                              (NN U-937)))
                          (-RRB- -RRB-)))
                      (PRN (-LRB- -LRB-)
                        (NP
                          (NP (NNP Figure) (CD 4A))
                          (CC and)
                          (NP (NNP Table) (CD 1)))
                        (-RRB- -RRB-)))))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Intriguingly))
    (, ,)
    (NP
      (NP
        (NP (DT a) (NN stretch))
        (PP (IN of)
          (NP (CD 13) (NNP CpG) (NNS sites))))
      (PRN (-LRB- -LRB-)
        (NP
          (NP (# #) (CD 10))
          (: --)
          (NP (CD 22) (: ;) (CD R2)))
        (-RRB- -RRB-)))
    (VP (VBD was)
      (VP (VBN detected)
        (PP (IN in) (IN between)
          (NP
            (NP (DT these) (NNS regions))
            (, ,)
            (SBAR
              (WHNP (WDT which))
              (S
                (VP (VBD were)
                  (ADJP (RB highly) (JJ methylated)
                    (PP (IN in)
                      (NP
                        (NP
                          (NP (NNS IRF-4-negative))
                          (PRN (-LRB- -LRB-)
                            (S
                              (VP (VB mean)
                                (NP
                                  (NP (NN number))
                                  (PP (IN of)
                                    (NP (JJ methylated) (NNS clones)))
                                  (SBAR
                                    (S
                                      (NP
                                        (NP (CD 7.1))
                                        (PP (IN of)
                                          (NP
                                            (NP (CD 8))
                                            (PP (IN with)
                                              (NP (CD 89) (NN %))))))
                                      (VP (VBD methylated)
                                        (NP (NNS CpGs))))))))
                            (-RRB- -RRB-)))
                        (ADJP
                          (ADJP (CC but)
                            (RB totally) (JJ non-methylated)
                            (PP (IN in)
                              (NP (NN IRF-4-positive) (NNS cells))))
                          (PRN (-LRB- -LRB-)
                            (NP
                              (NP (NNP Figure) (CD 4A))
                              (CC and)
                              (NP (NNP B)))
                            (-RRB- -RRB-)))))))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP
      (NP
        (NP (CD three) (NNP CpG) (NNS sites))
        (PP (IN at)
          (NP
            (NP (DT the)
              (ADJP
                (QP (CD 5) (CD ′)))
              (NN end))
            (PRN (-LRB- -LRB-)
              (NP
                (NP (# #) (CD 54))
                (, ,)
                (NP (CD 56))
                (, ,)
                (NP (CD 58)))
              (-RRB- -RRB-)))))
      (CC and)
      (NP
        (NP (CD two) (NNP CpG) (NNS motifs))
        (PP (IN at)
          (NP
            (NP (DT the)
              (ADJP
                (QP (CD 3) (CD ′)))
              (NN end))
            (PRN (-LRB- -LRB-)
              (NP
                (NP (# #) (CD 1))
                (, ,)
                (NP (CD 2)))
              (-RRB- -RRB-))))))
    (VP (VBD showed)
      (NP
        (NP
          (NP (DT this) (JJ direct) (NN correlation))
          (PP (IN between)
            (NP (JJ high) (NN methylation) (NN status))))
        (CC and)
        (NP
          (NP (NN absence))
          (PP (IN of)
            (NP (NN IRF-4) (NN expression))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP
      (NP (CD two) (NNP CpG) (NNS sites))
      (VP (VBN located)
        (PP (IN in)
          (NP
            (NP (DT a) (NNP NFκB))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (# #) (CD 48)))
              (-RRB- -RRB-))
            (CC and)
            (NP (DT a) (JJ SP1) (NN element))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (# #) (CD 45)))
              (-RRB- -RRB-))))))
    (VP (VBP are)
      (ADJP (RBR less) (JJ methylated)
        (PP (IN in)
          (NP
            (NP
              (ADJP (JJ IRF-4-positive)
                (PP (IN than)
                  (PP (IN in)
                    (NP (NNS IRF-4-negative)))))
              (NNS cells))
            (PRN (-LRB- -LRB-)
              (S
                (VP (VB mean)
                  (NP
                    (NP
                      (NP (NN number))
                      (PP (IN of)
                        (NP (JJ methylated) (NNS clones))))
                    (: :)
                    (NP
                      (NP (CD 1/8))
                      (PP (IN versus)
                        (NP (CD 8/8)))))))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (NP (DT These) (NNS results))
    (VP (VBP indicate)
      (NP
        (NP (DT the) (NN involvement))
        (PP (IN of)
          (NP (NNP CpG) (NN methylation))))
      (PP (IN in)
        (NP
          (NP (DT the) (NN regulation))
          (PP (IN of)
            (NP
              (NP (NN IRF-4) (NN expression))
              (PP (IN in)
                (NP (JJ leukemic) (NNS cells))))))))
    (. .)))

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB provide)
          (NP
            (NP (NN evidence))
            (PP (IN for)
              (NP
                (NP (DT a) (JJ direct) (NN effect))
                (PP (IN of)
                  (NP (JJ methylational) (NN status))))))
          (PP (IN on)
            (NP (NN IRF-4) (NN promoter) (NN activity))))))
    (NP (PRP we))
    (VP (VBD performed)
      (NP (NN reporter) (NN gene) (NNS assays))
      (PP (IN with)
        (NP (NN IRF-4) (NN promoter) (NNS constructs)))
      (PP (IN before)
        (CC and)
        (IN after)
        (NP (PRP$ their)
          (ADJP (IN in) (NN vitro))
          (NN methylation))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT A) (JJ complete) (NN methylation))
      (PP (IN of)
        (NP (DT these) (NNS constructs))))
    (VP (VBD was)
      (VP (VBN checked)
        (PP (IN via)
          (NP (NN restriction) (NNS assays)))
        (PP (IN with)
          (NP
            (NP (JJ methylation-sensitive) (NNS endonucleases))
            (PRN (-LRB- -LRB-)
              (NP (NN Figure) (CD 5A))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Intriguingly))
    (, ,)
    (NP
      (NP (NN methylation))
      (PP (IN of)
        (NP (DT the) (NN IRF-4) (NN promoter))))
    (ADVP (RB significantly))
    (VP (VBD decreased)
      (NP (NN promoter) (NN activity))
      (PP (IN in)
        (NP (NN IRF-4-positive) (NN SD-1) (NNS cells)))
      (PP (IN by)
        (NP
          (NP (CD 85.0) (NN %))
          (PRN (-LRB- -LRB-)
            (NP (NN Figure) (CD 5B))
            (-RRB- -RRB-)))))
    (. .)))

(ROOT
  (SINV
    (S
      (NP
        (NP (DT The) (VBG silencing) (NN effect))
        (PP (IN of)
          (NP (NNP CpG) (NN methylation))))
      (VP (VBD was) (RB not)
        (VP (VBN restricted)
          (PP (TO to)
            (NP (NN IRF-4-positive) (NNS cells))))))
    (, ,)
    (VP
      (ADVP (IN since)
        (PP (IN in)
          (ADJP (NN vitro) (JJ methylation))))
      (VBD led)
      (PP (TO to)
        (NP
          (NP (DT a)
            (ADJP (CD 92.9) (NN %))
            (NN abrogation))
          (PP (IN of)
            (NP (NN promoter) (NN activity)))))
      (PP (IN in)
        (NP (NNP IRF-4-negative) (NNP Jurkat))))
    (NP
      (NP (NNS cells))
      (PRN (-LRB- -LRB-)
        (NP (NN Figure) (CD 5C))
        (-RRB- -RRB-)))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (NN contrast)))
    (, ,)
    (NP
      (NP (NN control) (NN methylation))
      (PP (IN of)
        (NP
          (NP
            (NP (DT a) (NN reporter))
            (S
              (VP (VB construct)
                (PP (IN with)
                  (NP (DT a) (JJ different) (NN promoter)))))
            (PRN (-LRB- -LRB-)
              (NP (NNP FasL))
              (-RRB- -RRB-)))
          (CONJP (RB as) (RB well) (IN as))
          (NP (DT an) (JJ empty) (NN vector)))))
    (VP (VBD had)
      (NP
        (NP (DT no) (NN effect))
        (PP (IN on)
          (NP
            (NP (DT the) (NN reporter) (NN activity))
            (PRN (-LRB- -LRB-)
              (NP
                (NP (NNS data))
                (VP (RB not) (VBN shown)))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (NP (DT These) (NNS data))
    (VP (VBD proved)
      (NP
        (NP (DT a) (JJ direct) (NN association))
        (PP (IN between)
          (NP (NN methylation)
            (CC and)
            (NN activity)))
        (PP (IN of)
          (NP (DT the) (NN IRF-4) (NN promoter)))))
    (. .)))

(ROOT
  (S
    (SBAR (IN Since)
      (S
        (NP
          (NP (NN abundance))
          (PP (IN of)
            (NP (NNP DNMT)
              (CC and)
              (NNP MBP))))
        (VP (VBP contribute)
          (PP (TO to)
            (NP
              (NP (NN promoter) (NN regulation))
              (PP (IN via)
                (NP
                  (NP (NN methylation))
                  (PRN (-LRB- -LRB-)
                    (NP (CD 25,26,28))
                    (-RRB- -RRB-)))))))))
    (, ,)
    (NP (PRP we))
    (VP (VBD studied)
      (NP (PRP$ their) (NN mRNA) (NN expression))
      (S
        (VP (TO to)
          (VP (VB investigate)
            (NP (DT a) (JJ possible) (NN mechanism))
            (PP (IN for)
              (NP
                (NP (DT the)
                  (ADJP (JJ observed) (JJ methylation))
                  (NNS differences))
                (PP (IN in)
                  (NP (DT the) (NN IRF-4) (NN promoter)))))))))
    (. .)))

(ROOT
  (S
    (PP (TO To)
      (NP (DT this) (NN end)))
    (, ,)
    (NP (PRP we))
    (VP (VBD did) (RB not)
      (VP (VB detect)
        (NP
          (NP
            (NP (DT a) (JJ significant) (NN difference))
            (PP (IN in)
              (NP (NNP DNMT)))
            (PRN (-LRB- -LRB-)
              (NP (NNP DNMT1))
              (, ,)
              (NP (NNP DNMT3A)
                (CC and)
                (NNP DNMT3B))
              (-RRB- -RRB-)))
          (CC or)
          (NP
            (NP (NNP MBP))
            (PRN (-LRB- -LRB-)
              (NP (NNP MBD1))
              (, ,)
              (NP (NNP MBD2))
              (, ,)
              (NP (NNP MBD4)
                (CC and)
                (NNP MeCP))
              (-RRB- -RRB-)))
          (NP
            (NP (NN mRNA) (NN expression))
            (PP (IN between)
              (NP
                (NP
                  (ADJP (JJ IRF-4-positive)
                    (CC and)
                    (JJ -))
                  (JJ negative) (NNS cells))
                (PRN (-LRB- -LRB-)
                  (NP (NN Figure) (CD 5D))
                  (-RRB- -RRB-))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (NN fact)))
    (, ,)
    (S
      (NP (DT all))
      (VP (VBD analyzed)
        (SBAR
          (S
            (NP (NNS cells))
            (VP (VBD had)
              (NP
                (NP
                  (ADJP (JJ moderate) (TO to) (JJ high))
                  (NN mRNA) (NNS levels))
                (PP (IN of)
                  (NP (DT these) (NNP tested) (NNPS DNMT/MBPs)))))))))
    (CC and)
    (S
      (NP
        (NP (NNS differences))
        (PP (IN in)
          (NP (NN expression))))
      (VP (VBD were) (RB not)
        (VP (VBN correlated)
          (PP (IN with)
            (NP (NN IRF-4) (NN status))))))
    (. .)))

(ROOT
  (S
    (NP (DT These) (NNS results))
    (VP (VBP indicate)
      (NP
        (NP
          (NP (DT a) (JJ distinct) (NN cause))
          (PP (IN of)
            (NP
              (NP (DT the) (NN methylation) (NNS differences))
              (PP (IN in)
                (NP
                  (ADJP (JJ IRF-4-positive)
                    (CC and)
                    (JJ -))
                  (JJ negative) (NNS cells))))))
        (CONJP (RB rather) (IN than))
        (NP
          (NP (NNS changes))
          (PP (IN in)
            (NP (DT the) (NNP DNMT)
              (CC and)
              (NNP MBP) (NNP mRNA) (NN transcription))))))
    (. .)))

(ROOT
  (S
    (NP (JJ DISCUSSION) (JJ Many) (JJ genetic) (NNS lesions))
    (VP (VBP are)
      (VP (VBN known)
        (S
          (VP (TO to)
            (VP (VB influence)
              (NP
                (NP (NN gene) (NN expression))
                (PP (IN of)
                  (NP (NN tumor) (NN suppressor) (NNS genes)))))))))
    (. .)))

(ROOT
  (S
    (SBAR (IN Whereas)
      (S
        (NP
          (NP (NNS mutations))
          (CC and)
          (NP (NNS deletions)
            (CC or)
            (NNS insertions)))
        (VP (VBP have)
          (NP (JJ permanent) (NNS effects)))))
    (, ,)
    (NP (JJ reversible) (NNS mechanisms))
    (VP (VBP are)
      (NP
        (NP (NN gene) (NN methylation))
        (, ,)
        (CC or)
        (NP
          (NP (NN expression)
            (CC and)
            (NN activation))
          (PP (IN of)
            (NP (NN transcription) (NNS factors))))
        (, ,)
        (ADVP (RB respectively))))
    (. .)))

(ROOT
  (S
    (NP (PRP We))
    (VP
      (VP (VBD studied)
        (NP (DT a) (JJ putative) (NN cause))
        (PP (IN for)
          (NP
            (NP
              (ADJP (JJ absent) (JJ IRF-4))
              (NN expression))
            (PP (IN in)
              (NP (NN leukemia) (NNS cells))))))
      (CC and)
      (VP
        (ADVP (RB first))
        (VBD focused)
        (PP (IN on)
          (NP
            (NP (JJ genetic) (NNS aberrations))
            (PP (IN of)
              (NP (DT the) (NN promoter)))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (PRP We))
      (VP (VBD observed)
        (NP
          (NP (DT no) (JJ genetic) (NNS alterations))
          (PP (IN in)
            (NP
              (NP (DT the) (NN IRF-4) (NN promoter))
              (, ,)
              (SBAR
                (WHNP (WDT which))
                (S
                  (VP (MD can)
                    (VP (VB account)
                      (PP (IN for)
                        (NP
                          (NP (DT the) (NN lack))
                          (PP (IN of)
                            (NP (NN IRF-4) (NN expression))))))))))))))
    (: :)
    (S
      (NP
        (NP (DT The) (JJ detected) (NN base) (NN pair) (NNS changes))
        (PP
          (PP (IN at)
            (NP
              (NP
                (NP
                  (NP (NN position))
                  (NP
                    (QP (CD −) (CD 1081))))
                (PRN (-LRB- -LRB-)
                  (NP (NNP T) (NNP →) (NNP C) (NNPS substitution))
                  (-RRB- -RRB-))
                (, ,)
                (PP (IN at)
                  (NP (NN position) (NNP −) (CD 1068))))
              (PRN (-LRB- -LRB-)
                (NP (DT A) (NNP →) (NNP C) (NNP substitution))
                (-RRB- -RRB-))))
          (CC and)
          (PP (IN at)
            (NP (NN position)))
          (NP
            (NP
              (QP (CD −) (CD 116)))
            (PRN (-LRB- -LRB-)
              (NP (DT A) (NNP →) (NNP C) (NNP substitution))
              (-RRB- -RRB-)))))
      (VP (VBP are)
        (ADJP (RB unlikely) (JJ responsible)
          (PP (IN for)
            (NP
              (ADJP
                (ADJP (JJ absent) (JJ IRF-4-expression))
                (SBAR (IN since)
                  (S
                    (NP (DT the) (JJ first) (CD two) (NNS mutations))
                    (VP (VBD were)
                      (VP (VBN found)
                        (PP (DT both) (IN in)
                          (NP (NNS IRF-4-positive)
                            (CC and)
                            (NNS -))))))))
              (JJ negative) (NNS cells))))
        (SBAR (IN whereas)
          (S
            (NP (DT the) (JJ latter) (NN change))
            (VP
              (VP (VBD was) (RB not)
                (VP (VBN detected)
                  (ADVP (RB consistently))
                  (PP (IN in)
                    (NP
                      (NP (DT all) (NN IRF-4-negative))
                      (CC or)
                      (NP (JJ -) (JJ positive) (NNS cells))))))
              (CC and)
              (VP (MD may)
                (ADVP (RB thus))
                (VP (VB be)
                  (NP (DT a) (NN polymorphism)))))))))
    (. .)))

(ROOT
  (S
    (NP (DT All) (CD three) (NNS substitutions))
    (VP
      (VP (VBD did) (RB not)
        (VP (VB change)
          (NP
            (NP (DT any)
              (ADJP (JJ known) (JJ putative))
              (JJ transcription) (NN factor) (VBG binding) (NNS sites))
            (PRN (-LRB- -LRB-)
              (NP (CD 30,31))
              (-RRB- -RRB-)))))
      (CC and)
      (VP
        (ADVP (RB also))
        (VBP do) (RB not)
        (VP
          (VP (VB affect)
            (NP (DT any) (NN restriction) (NNS sites)))
          (CC or)
          (VP (VB primer)
            (NP
              (NP (VBG binding) (NNS sites))
              (PP (IN of)
                (NP (DT the) (JJ used) (NNS assays))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP
      (NP (JJ permanent) (JJ genetic) (NNS variations))
      (PP (IN in)
        (NP
          (NP (DT the) (NN IRF-4) (VBG coding) (NN sequence))
          (, ,)
          (PP (JJ such) (IN as)
            (NP
              (NP (NNS deletions)
                (CC or)
                (NNS mutations))
              (VP (VBG resulting)
                (PP (IN in)
                  (NP (NNS stop-codons)))))))))
    (VP (VBP have) (RB not)
      (VP (VBN been)
        (VP (VBN excluded)
          (PP (IN by)
            (NP (NN sequence) (NN analysis))))))
    (. .)))

(ROOT
  (S
    (SBAR (IN Since)
      (S
        (NP
          (NP (NN IRF-4) (NN expression))
          (PP (IN in)
            (NP
              (NP (NN cell) (NNS lines))
              (CC and)
              (NP (NNP CML)))))
        (VP (MD can)
          (VP (VB be)
            (VP (VBN induced)
              (PP (IN by)
                (NP
                  (NP
                    (ADJP (JJ demethylation)
                      (CC and)
                      (JJ successful))
                    (JJ IFN-α) (NN therapy))
                  (PRN (-LRB- -LRB-)
                    (NP (CD 3))
                    (-RRB- -RRB-)))))))))
    (, ,)
    (ADVP (RB respectively))
    (, ,)
    (NP
      (NP (DT the) (NN existence))
      (PP (IN of)
        (NP (JJ such) (JJ genetic) (NNS aberrations))))
    (VP (VBZ seems)
      (ADJP (JJ unlikely)))
    (. .)))

(ROOT
  (S
    (NP (PRP We))
    (ADVP (RB then))
    (VP (VBD investigated)
      (SBAR (IN whether)
        (S
          (NP
            (NP (DT the)
              (ADJP (RB previously) (JJ described))
              (NN down-regulation))
            (PP (IN of)
              (NP
                (NP (NN IRF-4) (NN expression))
                (PP (IN in)
                  (NP (JJ human) (JJ myeloid) (NNS leukemias))))))
          (VP (VBD was)
            (ADJP (JJ due)
              (PP (TO to)
                (NP
                  (NP (DT a) (NN differential) (NN hypermethylation))
                  (PP (IN of)
                    (NP (DT the) (NN promoter))))))
            (, ,)
            (SBAR (IN since)
              (S
                (NP
                  (NP (DT the) (JJ presented) (NN re-expression))
                  (ADJP (JJ due)
                    (PP (TO to)
                      (NP (NNP AzadC-treatment)))))
                (VP (MD might)
                  (ADVP (RB also))
                  (VP (VB be)
                    (NP
                      (NP (DT a) (NN result))
                      (PP (IN of)
                        (NP
                          (NP (NN activation))
                          (PP (IN of)
                            (NP
                              (NP (JJ positive) (JJ transcriptional) (NNS regulators))
                              (PP (IN of)
                                (NP (NN IRF-4))))))))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Methylation))
      (PP (IN of)
        (NP (NNP CpG) (NNS sites))))
    (VP
      (VP (VBZ is)
        (NP
          (NP (DT a) (JJ common) (NN mechanism))
          (PP (IN of)
            (NP
              (NP (VBG silencing) (NNS genes))
              (PP (IN in)
                (NP (NN leukemia)))))))
      (CC and)
      (VP (VBZ has)
        (ADVP (RB also))
        (VP (VBN been)
          (VP (VBN shown)
            (PP
              (PP (IN for)
                (NP
                  (NP (DT another) (NNP IRF))
                  (, ,)
                  (NP
                    (NP (NN IRF-7))
                    (PRN (-LRB- -LRB-)
                      (NP (CD 35))
                      (-RRB- -RRB-)))))
              (CC and)
              (PP (IN for)
                (NP
                  (NP
                    (NP (NNP PU) (CD .1))
                    (PRN (-LRB- -LRB-)
                      (NP (CD 36))
                      (-RRB- -RRB-)))
                  (, ,)
                  (NP
                    (NP (DT an) (VBG interacting) (NN partner))
                    (PP (IN of)
                      (NP (NN IRF-4)))))))))))
    (. .)))

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB elucidate)
          (NP
            (NP (DT the) (NN relevance))
            (PP (IN of)
              (NP
                (NP (DT this) (NN mechanism))
                (PP (IN for)
                  (NP
                    (NP (DT the) (NN regulation))
                    (PP (IN of)
                      (NP (NN IRF-4) (NN expression)))))))))))
    (, ,)
    (NP (JJ various) (JJ leukemic) (NNS cells))
    (VP (VBD were)
      (VP (VBN treated)
        (PP (IN with)
          (S
            (VP (VBG demethylating)
              (SBAR
                (S
                  (NP (NNS agents)
                    (CC and)
                    (NNS promoters))
                  (VP (VBD were)
                    (VP (VBN sequenced)
                      (PP (IN after)
                        (NP (JJ bisulfite) (NN treatment))))))))))))
    (. .)))

(ROOT
  (S
    (NP (PRP We))
    (VP (VBD found)
      (SBAR (IN that)
        (S
          (NP (NN IRF-4) (NN expression))
          (VP (MD could)
            (ADVP (RB indeed))
            (VP (VB be)
              (VP (VBN connected)
                (PP (TO to)
                  (NP
                    (NP (DT the) (NN methylation) (NN status))
                    (PP (IN of)
                      (NP (JJ distinct) (NN CpG) (NNS motifs)))))
                (PP (IN in)
                  (NP (DT the) (NN IRF-4) (NN promoter)))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (NNP Figure) (CD 4A)))
    (, ,)
    (NP (DT those) (NNP CpG) (NNS sites))
    (VP (VBP are)
      (VP (VBN shown)
        (NP
          (NP (-LRB- -LRB-) (JJ bottom) (NN line) (-RRB- -RRB-))
          (, ,)
          (SBAR (WP$ whose)
            (S
              (NP (NN hypermethylation))
              (VP (MD may)
                (VP (VB account)
                  (PP (IN for)
                    (NP
                      (NP (DT the) (NN absence))
                      (PP (IN of)
                        (NP (NN IRF-4) (NN expression)))))
                  (PP (IN in)
                    (NP (DT the) (JJ respective) (NNS cells))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP
        (NP (CD One))
        (PP (IN of)
          (NP (PRP them))))
      (PRN (-LRB- -LRB-)
        (NP
          (QP (# #) (CD 54)))
        (-RRB- -RRB-)))
    (VP (VBZ is)
      (ADJP (JJ adjacent))
      (PP (TO to)
        (NP
          (NP (DT an) (JJ identified) (JJ regulatory) (NN element))
          (PRN (-LRB- -LRB-)
            (NP (NNP NFκB-site))
            (-RRB- -RRB-))))
      (, ,)
      (VP (VBG indicating)
        (NP
          (NP (DT a) (JJ possible) (NN involvement))
          (PP (IN of)
            (NP (DT this) (NN site))))))
    (. .)))

(ROOT
  (S
    (PP (IN At)
      (NP
        (NP (CD two) (JJ further) (NNP CpG) (NNS sites))
        (PRN (-LRB- -LRB-)
          (NP
            (NP (# #) (CD 48))
            (, ,)
            (NP (CD 45)))
          (-RRB- -RRB-))))
    (NP
      (NP (DT the) (NN methylation) (NN status))
      (PP (IN in)
        (NP (NNS IRF-4-positive))))
    (VP (VBD was)
      (ADJP (JJR lower))
      (PP (IN than)
        (NP
          (NP (DT that))
          (PP (IN of)
            (NP (NN IRF-4-negative) (NNS cells))))))
    (. .)))

(ROOT
  (S
    (NP (DT These) (NNP CpG) (NNS sites))
    (VP (VBP are)
      (VP (VBN located)
        (UCP
          (PP (IN in)
            (NP
              (NP (DT an) (NNP NFκB))
              (CC and)
              (NP
                (NP (DT an) (JJ SP1) (NN element))
                (PRN (-LRB- -LRB-)
                  (NP (CD 31))
                  (-RRB- -RRB-)))))
          (CC and)
          (RB thus)
          (SBAR
            (S
              (VP (MD may)
                (ADVP (RB also))
                (VP (VB play)
                  (NP (DT a) (NN role))
                  (PP (IN in)
                    (NP
                      (NP (NN regulation))
                      (PP (IN of)
                        (NP (NN IRF-4) (NN expression))))))))))))
    (. .)))

(ROOT
  (S
    (NP (PRP It))
    (VP (VBZ has)
      (VP (VBN been)
        (VP (VBN shown)
          (SBAR (IN that)
            (S
              (NP (NNP NFκB) (NNS elements))
              (VP (VBP play)
                (NP (DT an) (JJ important) (NN role))
                (PP (IN in)
                  (NP (NN IRF-4) (NN induction)))
                (SBAR (IN as)
                  (S
                    (NP (NN IRF-4) (NN expression))
                    (VP (VBZ depends)
                      (PP (IN on)
                        (NP
                          (NP (VBG binding))
                          (PP (IN of)
                            (NP
                              (NP (DT the) (NN transactivator) (NN c-Rel))
                              (PP (TO to)
                                (NP
                                  (NP (DT these) (NNS elements))
                                  (PP (IN in)
                                    (NP
                                      (NP (DT the) (NN IRF-4) (NN promoter))
                                      (PRN (-LRB- -LRB-)
                                        (NP (CD 31,37))
                                        (-RRB- -RRB-)))))))))))))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP
      (NP (NN methylation))
      (PP (IN of)
        (NP
          (NP (DT the) (JJ central) (NN CpG))
          (PP (IN in)
            (NP (DT the) (NNP NFκB) (NN element))))))
    (VP (VBZ inhibits)
      (NP
        (NP
          (ADJP (JJ binding)
            (PP (IN of)
              (NP (DT the) (NNP NFκB) (NN protein))))
          (NNS complexes))
        (PRN (-LRB- -LRB-)
          (NP (CD 38))
          (-RRB- -RRB-))
        (, ,)
        (VP (VBG promoting)
          (NP
            (NP (DT the) (NN significance))
            (PP (IN of)
              (NP
                (NP (DT the)
                  (ADJP (JJ observed) (JJ methylation))
                  (NNS differences))
                (PP (IN in)
                  (NP
                    (ADJP (JJ IRF-4-positive)
                      (CC and)
                      (JJ -))
                    (JJ negative) (NNS cells)))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Via))
      (PP (IN in)
        (NP (JJ vitro) (NN methylation)
          (CC and)
          (NN reporter) (NN gene))))
    (VP (VBZ assays)
      (SBAR
        (S
          (NP (PRP we))
          (VP (MD could)
            (ADVP (RB clearly))
            (VP (VB appoint)
              (NP
                (NP (DT the) (NN silencing))
                (PP (IN of)
                  (NP (DT the) (NN IRF-4) (NN promoter))))
              (PP (TO to)
                (NP
                  (NP (DT a) (NN methylation) (NN effect))
                  (, ,)
                  (SBAR
                    (WHNP (WDT which))
                    (S
                      (VP (MD may)
                        (ADVP (RB thus))
                        (VP (VB be)
                          (NP
                            (NP (DT the) (NN mechanism))
                            (PP (IN of)
                              (NP
                                (NP (NN IRF-4) (NN deregulation))
                                (PP (IN in)
                                  (NP (NN vivo)))))))))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (CD One) (JJ possible) (NN cause))
      (PP (IN for)
        (NP
          (NP (DT the) (JJ aberrant) (NN methylation))
          (PP (IN in)
            (NP (NNS tumorigenesis))))))
    (VP (VBZ is)
      (NP
        (NP (DT an) (VBN increased) (NN level))
        (PP (IN of)
          (NP (NNP DNMTs)))
        (PP (IN during)
          (NP (DT the) (JJ pathogenetic) (NN process)))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (NN colon) (, ,) (NN lung)
        (CC and)
        (NN hematologic) (NNS malignancies)))
    (, ,)
    (NP
      (NP
        (NP (NN overexpression))
        (PP (IN of)
          (NP (NNP DNMT1))))
      (, ,)
      (NP (DT a) (NN maintenance) (NN DNMT))
      (, ,))
    (VP (VBZ has)
      (VP (VBN been)
        (VP (VBN detected)
          (PRN (-LRB- -LRB-)
            (NP
              (NP (CD 39))
              (: --)
              (NP (CD 41)))
            (-RRB- -RRB-)))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (PRP it))
    (VP (VBZ has)
      (VP (VBN been)
        (VP (VBN shown)
          (SBAR (IN that)
            (S
              (NP
                (NP (NNP CML) (NNS cells))
                (PP (IN in)
                  (NP (DT the) (JJ acute) (NN phase))))
              (VP (VBD exhibited)
                (NP
                  (NP (JJ elevated) (NNS levels))
                  (PP (IN of)
                    (NP
                      (NP (DT the) (CD three) (VBN known) (NNS DNMTs))
                      (, ,)
                      (SBAR (IN while)
                        (S
                          (NP
                            (NP (NNP CML) (NNS cells))
                            (PP (IN in)
                              (NP (JJ chronic) (NN phase))))
                          (VP (VBD expressed)
                            (NP
                              (NP (JJ normal) (NNS levels))
                              (PP (IN of)
                                (NP (NNP DNMTs))))
                            (SBAR (IN if)
                              (S
                                (VP (VBN compared)
                                  (PP (IN with)
                                    (NP (JJ normal) (NN bone) (NN marrow) (NNS cells)))
                                  (PRN (-LRB- -LRB-)
                                    (NP (CD 25))
                                    (-RRB- -RRB-)))))))))))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Interestingly))
    (, ,)
    (NP
      (NP (DT a) (JJ positive) (NN correlation))
      (PP (IN between)
        (NP
          (NP (JJ DNMT1) (NN expression) (NNS levels)
            (CC and)
            (NNS hypermethylation))
          (PP (IN of)
            (NP (CD p15INK4b))))))
    (VP (VBZ has)
      (VP (VBN been)
        (VP (VBN detected)
          (PP (IN in)
            (NP
              (NP (NNP AML))
              (PRN (-LRB- -LRB-)
                (NP (CD 25))
                (-RRB- -RRB-)))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN work)))
    (, ,)
    (NP (PRP we))
    (VP (VBD did) (RB not)
      (VP (VB detect)
        (NP
          (NP (JJ significant) (NN mRNA) (NN expression) (NNS differences))
          (PP (IN of)
            (NP (JJ selected) (NNP DNMT)
              (CC or)
              (NNP MBP))))
        (, ,)
        (S
          (VP (VBG making)
            (S
              (NP (PRP it))
              (NP
                (NP (DT an) (JJ unlikely) (NN cause))
                (PP (IN for)
                  (NP (DT the)
                    (UCP
                      (ADJP (JJ observed) (JJ methylation))
                      (CC and)
                      (RB thus)
                      (ADJP (JJ IRF-4)))
                    (NN expression) (NNS differences)))
                (PP (IN in)
                  (NP (NN leukemia) (NNS cells)))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NN finding))
      (SBAR (IN that)
        (S
          (NP (NN IRF-4) (NN expression))
          (VP (VBZ is)
            (VP (VBN silenced)
              (PP (IN by)
                (NP (NN promoter) (NN hypermethylation))))))))
    (VP (MD might)
      (VP (VB represent)
        (NP
          (NP (DT a) (NN mechanism))
          (SBAR
            (WHNP (WDT that))
            (S
              (VP (VBZ accounts)
                (PP (IN for)
                  (NP
                    (NP (DT the)
                      (ADJP (RB previously) (JJ observed))
                      (NN loss))
                    (PP (IN of)
                      (NP
                        (NP (NN IRF-4) (NN expression))
                        (PP (IN in)
                          (NP (NNP CML)))))))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Indeed))
    (, ,)
    (NP
      (NP (JJ several) (JJ clinical) (NNS trials))
      (PP (IN with)
        (NP
          (NP (NN leukemia) (NNS patients)
            (CC and)
            (NNS patients))
          (PP (IN with)
            (NP (JJ myelodysplastic) (NNS syndromes))))))
    (VP (VBD demonstrated)
      (NP
        (NP (DT the) (JJ potential) (JJ clinical) (NN benefit))
        (PP (IN of)
          (NP (DT a) (NN treatment))))
      (PP (IN with)
        (NP
          (NP (VBG demethylating) (NNS agents))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (CD 42))
              (: --)
              (NP (CD 45)))
            (-RRB- -RRB-)))))
    (. .)))

(ROOT
  (S
    (NP
      (NP
        (NP (DT The) (NN expression))
        (PP (IN of)
          (NP (DT another) (NNP IRF))))
      (, ,)
      (NP
        (NP (NNP IFN) (NN consensus) (NN sequence))
        (NP
          (NP (JJ binding) (NN protein))
          (PRN (-LRB- -LRB-)
            (NP (NNP ICSBP/IRF) (CD -8))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBZ is)
      (VP (VBN impaired)
        (PP (IN in)
          (NP
            (NP
              (NP (JJ myeloid) (NNS leukemias))
              (ADJP (RB especially) (JJ CML)))
            (PRN (-LRB- -LRB-)
              (NP (CD 27,46,47))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S (CC But)
    (S
      (PP (IN in)
        (NP
          (NP (NN contrast))
          (PP (TO to)
            (NP (NN IRF-4)))))
      (, ,)
      (NP
        (NP (DT the) (NN loss))
        (PP (IN of)
          (NP (DT this) (NNP IRF))))
      (VP (MD could) (RB not)
        (VP (VB be)
          (VP (VBN reverted)
            (PP (IN in)
              (NP
                (NP (JJ ICSBP-negative) (NN cell) (NNS lines))
                (PRN (-LRB- -LRB-)
                  (NP (NNP EM-2))
                  (, ,)
                  (NP (NNP CML-T1))
                  (, ,)
                  (NP (NNP K-562)
                    (CC and)
                    (NNP LAMA-84))
                  (-RRB- -RRB-))))
            (PP (IN by)
              (NP (NN treatment)))
            (PP (IN with)
              (NP
                (NP (NNP AzadC))
                (PRN (-LRB- -LRB-)
                  (NP (NN Figure) (CD 6))
                  (-RRB- -RRB-))))))))
    (CC and)
    (S
      (NP (NNP AzadC))
      (VP (VBZ has)
        (NP
          (NP (DT no) (NN effect))
          (PP (IN on)
            (NP
              (NP (NNP ICSBP) (NNS levels))
              (PP (IN in)
                (NP
                  (NP (JJ ICSBP-positive) (NN U-937) (NNS cells))
                  (PRN (-LRB- -LRB-)
                    (NP (NN Figure) (CD 6))
                    (-RRB- -RRB-)))))))))
    (. .)))

(ROOT
  (S
    (NP (DT These) (NNS data))
    (VP (VBP suggest)
      (NP
        (NP (DT a) (JJ distinct) (JJ regulatory) (NN mechanism))
        (PP (IN for)
          (NP (DT these) (CD two) (NNS IRFs)))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NN IRF-4))
      (, ,)
      (ADJP (JJ similar)
        (PP (TO to)
          (NP (JJ many) (JJ other) (JJ classical) (NN tumor) (NN suppressor) (NNS genes)))
        (NP (CD p15INK4b) (, ,) (CD p16INK4a)
          (CC or)
          (CD p53)))
      (, ,))
    (VP (MD may)
      (ADVP (RB thus))
      (VP (VB be)
        (NP
          (NP (DT a) (NN subject))
          (PP (IN of)
            (NP
              (NP (NNS alterations))
              (PP (IN in)
                (NP
                  (NP (DT the) (NN promoter) (NN methylation) (NN status))
                  (VP (VBG leading)
                    (PP (TO to)
                      (NP
                        (NP (NN expression) (NNS changes))
                        (, ,)
                        (SBAR
                          (WHNP (WDT which))
                          (S
                            (VP (MD might)
                              (VP (VB contribute)
                                (PP (TO to)
                                  (NP
                                    (NP (DT the) (NN initiation) (NN and/or) (NN progression))
                                    (PP (IN of)
                                      (NP (NN cancer)))))))))))))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Still))
    (, ,)
    (NP
      (NP (DT the)
        (ADJP (JJ obvious) (JJ functional))
        (NN diversity))
      (PP (IN of)
        (NP (NN IRF-4))))
    (VP
      (VP (VBZ remains)
        (ADJP (JJ remarkable)))
      (CC and)
      (VP (MD can) (RB not)
        (VP (VB be)
          (VP
            (ADVP (RB fully))
            (VBN explained)
            (PP (IN by)
              (NP (DT the) (NNP IRF-4) (NN promoter) (NN methylation) (NN status)))))))
    (. .)))

(ROOT
  (S
    (PP (IN For)
      (NP (NN example)))
    (, ,)
    (NP (NNP IRF-4))
    (VP (VBZ is)
      (ADVP (RB primarily))
      (VP (VBN known)
        (PP (IN for)
          (NP (PRP$ its) (JJ oncogenic) (NNS features)))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP (JJ multiple) (NN myeloma))
        (PRN (-LRB- -LRB-)
          (NP (NNP MM))
          (-RRB- -RRB-))))
    (NP
      (NP (DT a) (NN translocation))
      (PP (IN on)
        (NP (NN chromosome) (NNS 14q))))
    (VP (VBD was)
      (VP (VBN reported)
        (S
          (VP (TO to)
            (VP (VB lead)
              (PP (TO to)
                (NP
                  (NP
                    (NP (DT a) (NN fusion) (NN gene))
                    (PP (IN of)
                      (NP
                        (NP (NN immunoglobulin) (NN heavy-chain))
                        (PRN (-LRB- -LRB-)
                          (NP (NNP IgH))
                          (-RRB- -RRB-)))))
                  (CC and)
                  (NP
                    (NP (NN IRF-4))
                    (VP (VBG resulting)
                      (PP (IN in)
                        (NP
                          (NP (DT a) (JJ subsequent) (NN overexpression))
                          (PP (IN of)
                            (NP
                              (NP (NN IRF-4))
                              (PRN (-LRB- -LRB-)
                                (NP (CD 48,49))
                                (-RRB- -RRB-)))))))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP (JJ abundant) (NN IRF-4) (NN expression))
    (VP (VBD was)
      (VP (VBN found)
        (S
          (VP (TO to)
            (VP (VB be)
              (NP
                (NP (DT a) (NN marker))
                (PP (IN for)
                  (NP
                    (NP (JJ various) (NNS subsets))
                    (PP (IN of)
                      (NP
                        (NP (NNS lymphomas))
                        (PRN (, ,)
                          (PP (JJ such) (IN as)
                            (NP
                              (NP (JJ diffuse) (JJ large) (JJ B-cell) (NNS lymphomas))
                              (, ,)
                              (NP (JJ primary) (NN effusion) (NN lymphoma))
                              (, ,)
                              (CC and)
                              (NP (JJ marginal) (NN zone) (NN lymphoma))))
                          (, ,))
                        (CC and)
                        (NP (JJ adult) (JJ T-cell) (NN leukemia))
                        (PRN (-LRB- -LRB-)
                          (NP
                            (NP (CD 11,31,50))
                            (: --)
                            (NP (CD 52)))
                          (-RRB- -RRB-))))))))))))
    (. .)))

(ROOT
  (S
    (NP (DT This))
    (VP (VBZ draws)
      (NP
        (NP (DT a)
          (ADJP (RBR more) (JJ complex))
          (NN picture))
        (PP (IN of)
          (NP
            (NP (DT the) (NN role))
            (PP (IN of)
              (NP (NN IRF-4)))))))
    (. .)))

(ROOT
  (SINV
    (VP (VBG Down-regulation)
      (PP (IN of)
        (NP (NN IRF-4))))
    (VP (MD may)
      (VP (VB promote)
        (NP (NNS leukemogenesis))
        (PP (IN in)
          (NP
            (NP (JJ myeloid) (NN cell) (NN context))
            (NP
              (LST (-LRB- -LRB-) (LS 3) (-RRB- -RRB-))
              (, ,)
              (SBAR
                (WHNP (WDT which))
                (S
                  (VP (VBD was)
                    (ADVP (RB recently))
                    (VP (VBN confirmed)
                      (PP (IN in)
                        (NP (NNP IRF-4) (NNP −))))))))))))
    (PRN (: /)
      (S
        (NP (NNP −) (NNP ICSBP))
        (ADJP (JJ −)))
      (: /))
    (NP
      (NP (JJ −) (JJ double) (JJ knock-out) (NNS mice))
      (PRN (-LRB- -LRB-)
        (NP (CD 53))
        (-RRB- -RRB-))
      (, ,)
      (SBAR (IN while)
        (S
          (NP (NN IRF-4) (NN up-regulation))
          (VP (MD may)
            (VP (VB induce)
              (NP (DT a) (NN growth) (NN advantage))
              (PP (IN in)
                (NP
                  (NP (NNS lymphomas))
                  (CC or)
                  (NP
                    (NP (NNP MM))
                    (PRN (-LRB- -LRB-)
                      (NP (CD 48))
                      (-RRB- -RRB-))))))))))
    (. .)))

(ROOT
  (S
    (S
      (VP (VBN Taken)
        (ADVP (RB together))))
    (, ,)
    (NP (PRP$ our) (NNS data))
    (VP (VBP suggest)
      (SBAR
        (SBAR (IN that)
          (S
            (NP (NN IRF-4) (NN promoter) (NN methylation))
            (VP (VBZ regulates)
              (NP (NN IRF-4) (NN expression)))))
        (, ,)
        (CC and)
        (SBAR (IN that)
          (S
            (NP
              (NP (JJ aberrant) (NN expression))
              (PP (IN of)
                (NP
                  (NP (NN IRF-4))
                  (PP (IN in)
                    (NP
                      (NP (JJ certain) (NNS types))
                      (PP (IN of)
                        (NP (NN leukemia))))))))
            (VP (MD may)
              (VP (VB be)
                (NP
                  (NP (DT a) (NN consequence))
                  (PP (IN of)
                    (NP (NN IRF-4) (NN promoter) (NN hypermethylation))))))))))
    (. .)))

(ROOT
  (S
    (NP (NNP Figure)
      (CC and)
      (NNP Table))
    (VP (VBZ captions)
      (NP
        (NP (NNP Figure) (CD 1))
        (: :)
        (NP
          (NP (NNP Correlation))
          (PP (IN of)
            (NP (NN IRF-4) (NN mRNA) (NN expression)
              (CC and)
              (NN nucleotide) (NNS changes)))))
      (PP (IN in)
        (NP (DT the) (NN IRF-4) (NN promoter))))
    (. .)))

(ROOT
  (NP
    (NP (-LRB- -LRB-) (NNP A) (-RRB- -RRB-) (NNP RT))
    (: --)
    (NP
      (NP (NNP PCR))
      (PP (IN of)
        (NP (JJ different) (JJ hematopoietic) (NN cell) (NNS lines))))
    (. .)))

(ROOT
  (S
    (NP (-LRB- -LRB-) (NNP B) (-RRB- -RRB-))
    (VP (VBP nucleotide)
      (NP (NNS changes))
      (PP
        (PP (IN in)
          (NP
            (NP (DT the) (NN promoter))
            (PP (IN of)
              (NP (NNS IRF-4-positive)))))
        (CC or)
        (PRN (: -)
          (NP
            (NP (JJ negative) (NNS cells))
            (PP (IN in)
              (NP (NN comparison)))))
        (PP (TO to)
          (NP
            (NP (DT the) (JJ germline) (NN sequence))
            (PP (IN at)
              (NP
                (NP (NNP positions) (CD 98) (, ,) (CD 111))
                (CC and)
                (NP (CD 1063) (-LRB- -LRB-) (NN GenBank) (NN accession) (RB no))))))))
    (. .)))

(ROOT
  (S
    (VP (VBD U52683) (-RRB- -RRB-)
      (NP
        (NP
          (NP (, ,)
            (NP (JJ representing) (NN nucleotide))
            (JJ −) (NNS 1081))
          (, ,)
          (NP
            (NP
              (QP (CD −) (CD 1068)
                (CC and)
                (CD −) (CD 116)))
            (PRN (-LRB- -LRB-)
              (NP (CD 30))
              (-RRB- -RRB-)))
          (CC or)
          (NP
            (NP (NNP −) (CD 1094) (, ,) (CD −))
            (NP (CD 1081))))
        (CC and)
        (NP
          (NP (NNP −) (CD 129))
          (PRN (-LRB- -LRB-)
            (NP (CD 31))
            (-RRB- -RRB-))))
      (, ,)
      (ADVP (RB respectively)))
    (. .)))

(ROOT
  (NP
    (NP (NNP Figure) (CD 2))
    (: :)
    (NP
      (NP (NNP Expression))
      (PP (IN of)
        (NP
          (NP (NN IRF-4))
          (PP (IN in)
            (NP
              (NP (JJ hematopoietic) (NNS cells))
              (PP (IN after)
                (NP
                  (NP (NN treatment))
                  (PP (IN with)
                    (NP (NNP AzadC))))))))))
    (. .)))

(ROOT
  (S
    (NP (JJ Representative) (NNS cells)
      (CC and)
      (NNS experiments))
    (VP (VBP are)
      (VP (VBN shown)))
    (. .)))

(ROOT
  (S
    (S
      (NP (-LRB- -LRB-) (NNP A) (-RRB- -RRB-))
      (NP (NNP RT)))
    (: --)
    (S
      (NP (NNP PCR))
      (PP (IN after)
        (NP
          (NP
            (NP (NN incubation))
            (PP (IN of)
              (NP (NN CML-T1))))
          (CC and)
          (NP
            (NP
              (ADJP (JJ EM-2)
                (PP (IN with)
                  (NP (CD 0.5) (, ,) (CD 1)
                    (CC and)
                    (CD 3))))
              (NNP µM) (NNP AzadC))
            (PP (IN for)
              (NP (CD 72) (NN h)))))))
    (: ;)
    (S
      (NP (-LRB- -LRB-) (NNP B) (-RRB- -RRB-))
      (NP (NNP RT)))
    (: --)
    (S
      (NP (NNP PCR))
      (PP (IN after)
        (NP
          (NP (NN treatment))
          (PP (IN of)
            (NP
              (ADJP
                (ADJP (JJ CML-T1))
                (CC and)
                (ADJP (JJ EM-2)
                  (PP (IN with)
                    (NP
                      (NP (CD 3) (NN µM) (NNP AzadC))
                      (PP (IN for)
                        (NP (CD 24) (, ,) (CD 48)
                          (CC and)
                          (CD 72)))))))
              (NN h))))))
    (: ;)
    (S
      (NP (-LRB- -LRB-) (NNP C) (-RRB- -RRB-))
      (ADJP (JJ immunoblotting)
        (PP (IN after)
          (NP
            (NP
              (NP (NN treatment))
              (PP (IN of)
                (NP (NN CML-T1)
                  (CC and)
                  (NN LAMA-84)))
              (PP (IN with)
                (NP (CD 1))))
            (CC and)
            (NP
              (NP (CD 3) (NN µM) (NNP AzadC))
              (PP (IN for)
                (NP (CD 72) (NN h))))))))
    (: ;)
    (S
      (NP (-LRB- -LRB-) (NNP D) (-RRB- -RRB-))
      (NP (NNP RT)))
    (: --)
    (S
      (NP (NNP PCR))
      (PP (IN after)
        (NP
          (NP (NN treatment))
          (PP (IN of)
            (NP
              (ADJP (JJ BV-173)
                (PP (IN for)
                  (NP (CD 24) (, ,) (CD 48)
                    (CC and)
                    (CD 72))))
              (NN h)
              (CC and)
              (NN RPMI-8226)))
          (PP (IN for)
            (NP
              (NP (CD 72) (NN h))
              (PP (IN with)
                (NP (CD 3) (NN µM) (NNP AzadC))))))))
    (. .)))

(ROOT
  (NP
    (NP (NNP Figure) (CD 3))
    (: :)
    (NP
      (NP (NNP Restriction-PCR-assay))
      (PP (IN of)
        (NP
          (NP (DT the) (NN IRF-4) (NN promoter))
          (PP (IN in)
            (NP (JJ hematopoietic) (NNS cells))))))
    (. .)))

(ROOT
  (S
    (NP (-LRB- -LRB-) (NNP A) (-RRB- -RRB-))
    (VP (VBD Simplified)
      (NP
        (NP (NN structure))
        (PP (IN of)
          (NP (DT the) (NNP CpG) (NNS sites))))
      (PP (IN in)
        (NP
          (NP (DT the) (JJ human) (NN IRF-4) (NN promoter) (NN region))
          (PP (VBG including)
            (NP (NN exon) (CD 1))))))
    (. .)))

(ROOT
  (S
    (NP (DT Each) (NNP CpG) (NN motif))
    (VP (VBZ is)
      (VP
        (VP (VBN shown)
          (PP (IN as)
            (NP (NN circle))))
        (CC and)
        (VP (VBN numbered)
          (PRN (-LRB- -LRB-)
            (PP (IN above)
              (NP
                (NP (, ,) (JJ labeling) (NN beginning))
                (PP (IN from)
                  (NP (DT the) (CD 3) (JJ ′) (NN end) (VBG moving) (NNS upstream)))))
            (-RRB- -RRB-)))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NN Restriction) (NNS sites))
      (, ,)
      (NP
        (NP
          (NP (NNS fragments))
          (PRN (-LRB- -LRB-)
            (NP (NNP F1))
            (, ,)
            (NP (NNP F2))
            (-RRB- -RRB-)))
        (PP (IN of)
          (NP
            (NP (DT the) (NN restriction-PCR-assay)
              (CC and)
              (NNS regions))
            (VP (VBN amplified)
              (PP (IN after)
                (NP
                  (NP (JJ bisulfite) (NN treatment))
                  (PP (IN for)
                    (NP (NN sequencing))))))))))
    (VP (VBP are)
      (VP (VBN shown)
        (ADVP (RB below))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NNS numbers))
      (PP (IN in)
        (NP (NNS italics))))
    (VP (VBP refer)
      (PP (TO to)
        (NP (DT the) (NN sequence) (NNS data)))
      (PP (IN by)
        (NP
          (NP (NNP Grossman)
            (CC et)
            (NNP al.))
          (PRN (-LRB- -LRB-)
            (NP (CD 30))
            (-RRB- -RRB-)))))
    (. .)))

(ROOT
  (S
    (NP
      (PRN (-LRB- -LRB-)
        (NP (NNP B)
          (CC and)
          (NNP C))
        (-RRB- -RRB-)))
    (VP (VBZ Restriction-PCR-assay))
    (. .)))

(ROOT
  (NP
    (NP (NNP Restriction))
    (PP (IN of)
      (NP (NNP DNA)))
    (PP (IN with)
      (NP
        (NP
          (NP
            (NP (NNP EcoRI))
            (PRN (-LRB- -LRB-)
              (NP (NNP E))
              (, ,)
              (NP (DT no) (NN recognition) (NN site))
              (-RRB- -RRB-)))
          (, ,)
          (NP
            (NP (NNP HpaII))
            (PRN (-LRB- -LRB-)
              (NP (NNP H))
              (, ,)
              (NP (JJ sensitive))
              (-RRB- -RRB-)))
          (, ,)
          (NP
            (NP (NNS Bsp143II))
            (PRN (-LRB- -LRB-)
              (NP (NNP BII))
              (, ,)
              (NP (JJ sensitive))
              (-RRB- -RRB-)))
          (, ,)
          (NP
            (NP (NNS Bsh1236I))
            (PRN (-LRB- -LRB-)
              (NP (NNP BI))
              (, ,)
              (NP (JJ sensitive))
              (-RRB- -RRB-)))
          (CC and)
          (NP
            (NP (NNP MspI))
            (PRN (-LRB- -LRB-)
              (NP (NNP M))
              (, ,)
              (NP (NNP resistant))
              (-RRB- -RRB-))))
        (CC and)
        (NP (JJ subsequent) (NN PCR) (NN amplification))))
    (. .)))

(ROOT
  (S
    (NP
      (NP
        (NP (CD Three) (JJ representative) (NNS IRF-4-negative))
        (PRN (-LRB- -LRB-)
          (NP (NNP K-562))
          (, ,)
          (NP (NNP CML-T1))
          (, ,)
          (NP (NNP EM-2))
          (-RRB- -RRB-)))
      (CC and)
      (NP
        (NP (CD two) (NN IRF-4-positive) (NN cell) (NNS lines))
        (PRN (-LRB- -LRB-)
          (NP (NNP SD-1))
          (, ,)
          (NP (NNP BV-173))
          (-RRB- -RRB-))))
    (VP (VBP are)
      (VP (VBN shown)))
    (. .)))

(ROOT
  (S
    (NP (NN IRF-4) (NN expression))
    (VP (VBZ is)
      (VP (VBN denoted)
        (PP (IN on)
          (NP (DT the) (NN right)))))
    (. .)))

(ROOT
  (NP
    (NP
      (NP (-LRB- -LRB-) (NNP B) (-RRB- -RRB-))
      (NP
        (NP (NNP PCR-fragment) (CD 1))
        (PRN (-LRB- -LRB-)
          (NP (NNP F1))
          (-RRB- -RRB-))))
    (: ;)
    (NP
      (NP (-LRB- -LRB-) (NNP C) (-RRB- -RRB-))
      (NP
        (NP (NNP PCR-fragment) (CD 2))
        (PRN (-LRB- -LRB-)
          (NP (NNP F2))
          (-RRB- -RRB-))))
    (. .)))

(ROOT
  (NP
    (NP (NNP Figure) (CD 4))
    (: :)
    (NP
      (NP (JJ Methylation) (NN pattern))
      (PP (IN of)
        (NP
          (NP (NNP CpG) (NNS sites))
          (PP (IN in)
            (NP (DT the) (NN IRF-4) (NN promoter) (NN region))))))
    (. .)))

(ROOT
  (S
    (NP (NNP Methylation))
    (VP (VBZ is)
      (VP (VBN detected)
        (PP (IN via)
          (S
            (VP (VBG sequencing)
              (PP (IN of)
                (NP (JJ bisulfite-treated) (NN DNA)))
              (PP (IN from)
                (NP (JJ hematopoietic) (NNS cells))))))))
    (. .)))

(ROOT
  (S
    (NP (-LRB- -LRB-) (NNP A) (-RRB- -RRB-))
    (VP (VBZ Schematic)
      (NP
        (NP (NN figure))
        (PP (IN of)
          (NP (DT the) (NN IRF-4) (NN promoter) (NN region))))
      (PRN (-LRB- -LRB-)
        (S
          (VP (VB see)
            (NP (NNP Figure) (CD 3A))))
        (-RRB- -RRB-))
      (PP (IN for)
        (NP (DT each) (NN cell) (NN line))))
    (. .)))

(ROOT
  (S
    (S
      (NP (DT Each) (NNP CpG) (NN motif))
      (VP
        (VP (VBZ is)
          (VP (VBN shown)
            (PP (IN as)
              (NP (NN circle)))))
        (CC and)
        (VP (VBD numbered))))
    (PRN (-LRB- -LRB-)
      (PP (IN above))
      (PRN (, ,)
        (S
          (VP (VBG labeling)
            (PP (VBG beginning)
              (PP (IN from)
                (NP (DT the) (CD 3) (JJ ′) (NN end) (VBG moving) (NNS upstream)))))))
      (-RRB- -RRB-))
    (, ,)
    (S
      (NP (JJ white) (NNS circles))
      (VP (VBP mean)
        (NP
          (NP (DT no) (JJ methylated) (NN clone))
          (PRN (-LRB- -LRB-)
            (PP (IN from)
              (NP (CD eight)))
            (-RRB- -RRB-)))))
    (, ,)
    (S
      (NP (JJ gray) (NNS circles))
      (VP (VBP mean)
        (NP (CD one))
        (PP (TO to)
          (NP (CD four) (JJ methylated) (NNS clones)))))
    (CC and)
    (S
      (NP (JJ black) (NNS circles))
      (VP (VBP mean)
        (NP
          (QP (CD five) (TO to) (CD eight))
          (JJ methylated) (NNS clones))))
    (. .)))

(ROOT
  (S
    (NP (NN IRF-4) (NN expression))
    (VP (VBZ is)
      (VP (VBN denoted)
        (PP (IN on)
          (NP (DT the) (NN right)))))
    (. .)))

(ROOT
  (S
    (S
      (NP (NNP Below) (, ,) (NNP CpG) (NNP sites) (RB maybe))
      (ADJP (JJ responsible)
        (PP (IN for)
          (NP
            (NP (JJ methylation-dependent) (NN IRF-4) (NN silencing))
            (PRN (-LRB- -LRB-)
              (NP (NNS arrows))
              (-RRB- -RRB-))))))
    (: ;)
    (S
      (NP (NNP R1))
      (, ,)
      (NP
        (NP (NN region))
        (PP (IN with)
          (NP
            (ADJP (RB generally) (JJ high))
            (NN methylation)))))
    (: ;)
    (S
      (NP (NNP R2))
      (, ,)
      (NP
        (NP (NN region))
        (PP (IN with)
          (NP
            (NP (NN correlation))
            (PP (IN between)
              (NP (NN methylation)
                (CC and)
                (NN IRF-4) (NN expression)))))))
    (: ;)
    (S
      (NP (NNP R3))
      (, ,)
      (NP
        (NP (NN region))
        (PP (IN with)
          (NP
            (ADJP (RB generally) (JJ low))
            (NN methylation)))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ Putative) (VBG binding) (NNS sites))
      (PP (IN for)
        (NP (NN transcription) (NNS factors))))
    (VP (VBP are)
      (VP (VBN shown)
        (PP (IN above)
          (PRN (-LRB- -LRB-)
            (NP
              (NP (CD 5) (NNP ×) (NNP AP1))
              (, ,)
              (NP (CD 3) (JJ ×) (NNS Sp1))
              (, ,)
              (NP (CD 2) (JJ ×) (NNS Ets-1))
              (, ,)
              (NP (CD 2) (JJ ×) (NN κB))
              (, ,)
              (NP (CD 1) (JJ ×) (NN NF-3))
              (, ,)
              (NP (CD 1) (NNP ×) (NNP CD28RE))
              (, ,)
              (NP (CD 1) (NNP ×) (NNP PU) (CD .1)))
            (-RRB- -RRB-)))))
    (. .)))

(ROOT
  (S
    (NP
      (NP
        (PRN (-LRB- -LRB-)
          (NP (NNP B))
          (-RRB- -RRB-))
        (JJ Schematic) (NN figure))
      (PP (IN of)
        (NP
          (NP
            (NP (JJ specific) (NN region) (CD 2))
            (PRN (-LRB- -LRB-)
              (NP (NNP R2))
              (-RRB- -RRB-)))
          (: :)
          (NP
            (NP (NNP CpG) (NNS sites))
            (PP (IN from)
              (NP
                (NP (# #) (CD 10))
                (PP (TO to)
                  (NP (# #) (CD 22)))))))))
    (VP (VBP are)
      (VP (VBN shown)
        (PP (IN above))))
    (. .)))

(ROOT
  (S
    (NP
      (NP
        (NP (NNP Number))
        (PP (IN of)
          (NP (JJ methylated) (NNS clones))))
      (PRN (-LRB- -LRB-)
        (PP (IN from)
          (NP (CD eight)))
        (-RRB- -RRB-)))
    (VP (VBZ is)
      (VP (VBN shown)
        (PP (IN for)
          (NP (DT each) (NN cell) (NN line)))))
    (. .)))

(ROOT
  (NP
    (NP (NNP Figure) (CD 5))
    (: :)
    (NP
      (NP (NNP Investigation))
      (PP (IN of)
        (NP
          (NP (JJ putative) (NNS mechanisms))
          (PP (IN for)
            (NP (NN IRF-4) (NN deregulation))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP
        (PRN (-LRB- -LRB-)
          (NP
            (NP (NNP A))
            (: --)
            (NP (NNP C)))
          (-RRB- -RRB-))
        (NNS Influence))
      (PP (IN of)
        (NP
          (NP
            (ADJP (IN in) (NN vitro))
            (NN methylation))
          (PP (IN on)
            (NP
              (NP (DT the) (NN activity))
              (PP (IN of)
                (NP (DT an) (NN IRF-4) (NN promoter-reporter) (NN gene))))))))
    (VP (VB construct))
    (. .)))

(ROOT
  (NP
    (NP (-LRB- -LRB-) (NNP A) (-RRB- -RRB-) (NNP Control))
    (PP (IN of)
      (NP (JJ complete) (NN methylation)))
    (PP (IN via)
      (NP (NN restriction)))
    (. .)))

(ROOT
  (NP
    (NP (NNP Digestion))
    (PP
      (PP (IN of)
        (NP
          (NP
            (NP (DT the) (NN construct))
            (ADVP (IN before)))
          (PRN (-LRB- -LRB-)
            (ADJP (JJ lanes)
              (NP (CD 2) (, ,) (CD 4)
                (CC and)
                (CD 6)))
            (-RRB- -RRB-))))
      (CC and)
      (PP (IN after)
        (NP (NN methylation))))
    (PRN (-LRB- -LRB-)
      (ADJP (JJ lanes)
        (NP (CD 1) (, ,) (CD 3)
          (CC and)
          (CD 5)))
      (-RRB- -RRB-))
    (PP (IN with)
      (NP
        (NP (JJ respective)
          (ADJP
            (ADJP
              (ADJP (JJ methylation-sensitive))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (NNP HpaII))
                  (, ,)
                  (NP (NNS lanes) (CD 1)
                    (CC and)
                    (CD 2)))
                (-RRB- -RRB-)))
            (CC and)
            (ADJP (RB -) (JJ resistant)))
          (NNS endonucleases))
        (PRN (-LRB- -LRB-)
          (NP
            (NP (NNP MspI))
            (, ,)
            (NP (NNS lanes) (CD 3)
              (CC and)
              (CD 4)))
          (-RRB- -RRB-))))
    (. .)))

(ROOT
  (NP
    (NP
      (PRN (-LRB- -LRB-)
        (NP (NNP B)
          (CC and)
          (NNP C))
        (-RRB- -RRB-))
      (JJ Reporter) (NN gene))
    (ADJP (JJ assays)
      (PP
        (PP (IN with)
          (NP
            (NP (JJ non-methylated) (NN control))
            (PRN (-LRB- -LRB-)
              (NP (NN co))
              (-RRB- -RRB-))))
        (CC and)
        (PP (IN in)
          (NP
            (NP
              (ADJP
                (ADJP (NN vitro) (JJ methylated))
                (PRN (-LRB- -LRB-)
                  (VP (VBN met))
                  (-RRB- -RRB-)))
              (NN IRF-4) (NN promoter) (NNS constructs))
            (CC and)
            (NP
              (NP
                (NP (NN SD-1))
                (PRN (-LRB- -LRB-)
                  (NP (NNP B))
                  (-RRB- -RRB-)))
              (CC or)
              (NP
                (NP (JJ Jurkat) (NNS cells))
                (PRN (-LRB- -LRB-)
                  (NP (NNP C))
                  (-RRB- -RRB-))))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NN promoter) (NN activity))
    (VP (VBZ is)
      (VP (VBN displayed)
        (PP (IN as)
          (NP (JJ fold) (NN increase)))
        (PP (TO to)
          (NP
            (NP (JJ non-methylated) (NNS construct))
            (PRN (-LRB- -LRB-)
              (PP (IN via)
                (NP
                  (NP (NN ratio))
                  (PP (IN of)
                    (NP
                      (NP (NN firefly))
                      (PP (TO to)
                        (NP (NN renilla) (NN luciferase)))))))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (NP
    (NP (-LRB- -LRB-) (NNP D) (-RRB- -RRB-) (NNP Expression))
    (PP (IN of)
      (NP (NNP DNMT)
        (CC and)
        (NNP MBP) (NNP mRNA)))
    (PP (IN in)
      (NP (JJ various) (JJ hematopoietic) (NNS cells)))
    (. .)))

(ROOT
  (NP
    (NP (NNP RT))
    (: --)
    (NP
      (NP (NNP PCR))
      (PP (IN of)
        (NP (JJ various) (JJ hematopoietic) (NNS cells))))
    (: :)
    (NP
      (NP
        (NP (NN SD-1))
        (PRN (-LRB- -LRB-)
          (NP
            (QP (CD lane) (CD 1)))
          (-RRB- -RRB-)))
      (, ,)
      (NP
        (NP (NN RPMI-8226))
        (PRN (-LRB- -LRB-)
          (NP
            (QP (CD lane) (CD 2)))
          (-RRB- -RRB-)))
      (, ,)
      (NP
        (NP (NN BV-173))
        (PRN (-LRB- -LRB-)
          (NP
            (QP (CD lane) (CD 3)))
          (-RRB- -RRB-)))
      (, ,)
      (NP
        (NP (NN U-937))
        (PRN (-LRB- -LRB-)
          (NP
            (QP (CD lane) (CD 4)))
          (-RRB- -RRB-)))
      (, ,)
      (NP
        (NP (NN CML-T1))
        (PRN (-LRB- -LRB-)
          (NP
            (QP (CD lane) (CD 5)))
          (-RRB- -RRB-)))
      (, ,)
      (NP
        (NP (NN LAMA-84))
        (PRN (-LRB- -LRB-)
          (NP
            (QP (CD lane) (CD 6)))
          (-RRB- -RRB-)))
      (, ,)
      (NP
        (NP (NNP Jurkat))
        (PRN (-LRB- -LRB-)
          (NP
            (QP (CD lane) (CD 7)))
          (-RRB- -RRB-)))
      (, ,)
      (NP
        (NP (NN EM-2))
        (PRN (-LRB- -LRB-)
          (NP
            (QP (CD lane) (CD 8)))
          (-RRB- -RRB-)))
      (CC and)
      (NP
        (NP (NN K-562))
        (PRN (-LRB- -LRB-)
          (NP
            (QP (CD lane) (CD 9)))
          (-RRB- -RRB-))))
    (. .)))

(ROOT
  (S
    (NP (NN β-Actin))
    (VP (VBZ is)
      (VP (VBN used)
        (PP (IN as)
          (NP (NN reference)))))
    (. .)))

(ROOT
  (NP
    (NP (NNP Figure) (CD 6))
    (: :)
    (NP
      (NP (NNP Expression))
      (PP (IN of)
        (NP
          (NP (NNP ICSBP))
          (PP (IN in)
            (NP
              (NP (JJ hematopoietic) (NNS cells))
              (PP (IN after)
                (NP
                  (NP (NN treatment))
                  (PP (IN with)
                    (NP (NNP AzadC))))))))))
    (. .)))

(ROOT
  (S
    (NP (NNP Representative) (NNS experiments))
    (VP (VBP are)
      (VP (VBN shown)))
    (. .)))

(ROOT
  (NP
    (NP (-LRB- -LRB-) (NNP A) (-RRB- -RRB-) (NNP RT))
    (: --)
    (NP
      (NP
        (NP (NNP PCR))
        (PP (IN after)
          (NP
            (NP (NN treatment))
            (PP (IN of)
              (NP
                (ADJP
                  (ADJP (JJ CML-T1))
                  (CC and)
                  (ADJP (JJ EM-2)
                    (PP (IN with)
                      (NP
                        (NP (CD 3) (NN µM) (NNP AzadC))
                        (PP (IN for)
                          (NP (CD 24) (, ,) (CD 48)
                            (CC and)
                            (CD 72)))))))
                (NN h))))))
      (: ;)
      (NP
        (NP (-LRB- -LRB-) (NNP B) (-RRB- -RRB-))
        (NP (NNP RT)))
      (: --)
      (NP
        (NP (NNP PCR))
        (PP (IN after)
          (NP
            (NP
              (NP (NN treatment))
              (PP (IN of)
                (NP (NN LAMA-84))))
            (CC and)
            (NP
              (NP
                (ADJP (JJ U-937)
                  (PP (IN with)
                    (NP
                      (NP (CD 3) (NN µM) (NNP AzadC))
                      (PP (IN for)
                        (NP (CD 24) (, ,) (CD 48)
                          (CC and)
                          (CD 72))))))
                (NN h.))
              (NP (NNP Table) (CD 1))))))
      (: :)
      (NP
        (NP (NNP Sequencing))
        (PP (IN of)
          (NP
            (NP (JJ bisulfite-treated) (NN DNA))
            (PP (IN from)
              (NP (JJ hematopoietic) (NNS cells)))))))))

